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1. GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is divided into six sections. In the first introductory section, retinoid 
deficiency and toxicity are discussed, along with a general background of vitamin A related 
compounds. The history of A2 and its use in the MRDR assay is reviewed. Section 2 is a 
manuscript that has been prepared for submission to Teratology. This paper compares the 
teratogenic potency of three retinoids: z\\-tram isomers of Al, A2, and RA. Five levels of 
each retinoid were orally administered to pregnant dams on day 8.5 of gestation. Endpoint 
measures collected from the fetus at day 19.5 of gestation included percent terata, percent 
embryolethality, length (cm) and weight (g). Amounts of retinoids in tissues of both dams and 
offspring were also quantified. Section 3 is a manuscript that has been prepared for 
submission to Neurotoxicologv and Teratology. The purpose of this work was to determine if 
prenatal administration of dW-trans isomers of Al, A2, and RA effect postnatal behavior of 
six-week old rats. Comparisons were made between the compounds on the basis of live birth 
rates, overall growth and development, and significant behavioral changes caused by a range 
of three dosage levels from each of the three compounds. Section 4 is a manuscript that has 
been accepted by Nutrition Research for publication. This paper evaluates the vitamin A 
status of low-income pregnant women in Iowa by use of the MRDR assay. The serum 
concentrations of P-carotene, a-carotene, lycopene, and a-tocopherol were also measured. 
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Section S is a general sununary of the important findings of these papers, and section 6 lists 
the conclusions that emerge from the thesis work. 
Background 
The usage of vitamin A to treat night blindness has been chronicled for three and one-
half millennia. Early medical practitioners recommended consumption of ox-liver to 
ameliorate poor night vision. Others advised the application of liver juices directly to the eye. 
Modem science has revealed the validity of these methods, with evidence that livers of almost 
all animals are abundant in vitamin A, which allows dark adaptation of the retina. 
In the early 1900's, scientists involved in lipid research realized lipid portions of foods 
were essential for supporting life. Continued work demonstrated that lipids such as butter and 
cod-liver oil possessed a much greater ability to promote growth than other fats such as lard 
and almond oil. An essential growth factor termed "fat-soluble A," which was essential for 
normal growth and development, was identified. Thus began twentieth century research in the 
field of \dtamin A, or retinol (1). 
Today the entire family of compounds encompassing retinol, retinaldehyde, retinoic 
acid, and their many analogs are known as retinoids. The molecular structure of naturally 
occurring retinoids can be described by dividing the molecule into three parts: a trimethylated 
cyclohexene ring, a conjugated tetraene side-chain, and a polar carbon-oxygen group which 
completes the side chain and can exist in three possible oxidation states (Figure 1). However, 
few synthetic retinoids conform to this definition, since many are tricyclic, non-polyisoprenoid 
CHzOH REITNOL 
CH2OH 3,4-DIDEHYDRORETINOL 
COOH RETINOIC ACID 
Figure 1. Structures of the aJl-trans forms of the naturally occurring retinoids retinol, 
3,4-didehydroretinol, and retinoic acid. 
compounds. Therefore, a biological definition may be more suitable, as it incorporates all 
substances in the retinoid family. Spom and Roberts (2) have proposed that a retinoid be 
defined as: 
a substance that can elicit specific biologic responses by binding to and 
activating a specific receptor or set of receptors, with the program for the 
biologic response of the target cell residing in the retinoid receptor rather than 
in the retinoid ligand itself (p. 2). 
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Unquestionabh^ the discovery of the retinoid receptors, and the knowledge that retinoids 
regulate gene expression and ultimately the biological activities of all cells, has dramatically 
transformed the field of retinoid research. 
Several analogues and metabolites of retinol have interesting and useful biological 
effects. Retinoids are commonly used therapeutically for treatments against acne and other 
skin disorders. Large doses reduce recurrence of some forms of skin cancer. M\-trans 
retinoic acid has been shown to be effective in treating acute promyelocytic leukemia. Other 
retinoids are effective against a variety of chemically induced and spontaneous cancers (3). 
One very interesting retinoid caught the attention of scientists when, in 1937, a "new 
form of vitamin A" was discovered in the livers and other tissues of fresh-water fish. Vitamin 
A2 was isolated and subsequently characterized (4,5). The compound differed from retinol 
(Al) only in having one more conjugated double bond at the 3,4 position in the cyclohexene 
ring. Early work indicated that A2 was able to promote growth in vitamin A deficient rats, 
although experiments were confounded by the presence of substantial amounts of Al in the 
A2 extracts (6). Purer and larger yields of vitamin A became available for use when Farrer 
and workers (7) successfully synthesized dehydroretinol from methylretinoate by bromination 
followed by dehydrobromination to the methyl ester of dehydroretinoic acid. Addition of 
lithium aluminum hydride then yielded dehydroretinol. 
Biological studies in rats have indicated that purified A2 possesses 30-40% of the 
biological activity of vitamin Al in promoting growth, reproduction, and vision (7-10). 
Although A2 has been shown to be the predominant form of vitamin A in several species of 
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Although A2 has been shown to be the predominant form of vitamin A in several species of 
fish (11), it is present in only small amounts in mammals. A2 accounts for approximately 1-
2% of the total vitamin A stored in mouse liver (12) and has been shown to be metabolized to 
retinol in rats (13), suggesting possible interconversion of A1 and A2 in mammalian systems. 
A2 has also been identified in normal human epidermis, possibly as a metabolite of A1 (14-
17). 
Early work indicated that A2 produced a modified form of visual purple in the dark-
adapted retina of certain fi-esh water fish, allowing extra sensitivity to red light (18). Studies 
were undertaken in the 1940's to determine if A2 could increase the sensitivity of aviator's 
eyes to the red lights used for military identification. Shantz and workers (8) used a rat 
model, and discovered that A2 could almost entirely replace A1 in the retina of rats. 
However, the growth response was depressed for rats dosed at 0.11 i^mole of A2 for 12 
weeks, when compared to lower doses of vitamin A2 or equivalent doses of Al. Whether 
this phenomenon was the result of A2 toxicity, or a response to a contaminant in the A2 
preparation is not clear. Based on these findings, Millard and workers (19) dosed medical 
students with 9.75 mg A2 daily for 39 days. Results fi'om this study indicated that A2 
increased sensitivity to red light in humans. Subjects were monitored for signs of A2 toxicity, 
including: eye and skin effects, gastro-intestinal complaints, weight loss, and anemia. Blood 
levels of Al, calcium, phosphorus, and alkaline phosphatase were also taken. No toxicity of 
A2 was reported. 
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Assessment of Vitamin A Status 
Despite our increased understanding of vitamin A related compounds, vitamin A 
deficiency continues to be a serious nutritional problem in many parts of the world. Annual 
morbidity of xerophthalmia has reached approximately 5 million in children from third world 
countries. About one quarter million of these children become blind, and annual mortality is 
approximately 125,000. A series of changes in the eye, usually beginning with night blindness, 
progress to cause irreversible changes in the cornea, resulting in keratomalacia. Changes in 
the skin, such as follicular hyperkeratosis and phrynoderma are also evident during vitamin A 
deficiency. Immune function is also suppressed in deficient states of vitamin A, leading to 
increased viral and bacterial infections. Protein-calorie malnutrition and zinc deficiency 
exacerbate the situation. 
Within populations, children and pregnant and lactating women tend to be at greater 
risk for vitamin A deficiency. These periods of development, when proliferative growth and 
tissue development occur, increase the body's demand for vitamin A. While increased 
consumption of vitamin A containing foods can meet these demands, many individuals without 
adequate nutrition develop clinical vitamin A deficiency during these periods of development 
(20,21). 
While overt, clinical signs of vitamin A deficiency allow easy diagnosis of the 
condition, considerable irreversible damage to the eye may have already occurred. For 
instance, classical clinical assessment of vitamin A deficiency has included the presence of 
Bitot's spots with conjunctival xerosis, corneal xerosis, and corneal ulceration. Biochemical 
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assessment has also been widely used as a diagnostic tool. A semm concentration lower than 
0.35 iimol/L (<10 |ag/dl) has been used to indicate vitamin A deficiency, while levels in excess 
of 1.05 ^imol/L (>30 ng/dl) are associated with a satisfactory status. Serum concentrations 
falling between these levels, indicating a marginal vitamin A status, have been difficult to 
interpret. Subclinical deficiency of vitamin A is correlated with decreased growth and 
development, increased morbidity of infectious diseases, and increased risk of xerophthalmia 
and other ocular health problems. Sensitive methods for assessing marginal vitamin A status 
are needed for use in nutritional surveys of both individuals and populations. 
Dietary assessment has been employed to evaluate vitamin A sufficiency. 
Unfortunately, this method is labor intensive, and produces results that do not correlate well 
with other measures of vitamin A status. Isotope dilution techniques have been employed as 
useful techniques in measuring the relative content of total body vitamin A. Unfortunately, 
this method uses sophisticated equipment and techniques, limiting its usefiilness in large 
surveys or field work (21,22). 
A dose-response test for indirectly assessing marginal liver stores of vitamin A was 
developed for use both in individuals and populations (23). The relative dose response test 
(RDR) relies on the observation that apo-retinol-binding protein (RBP) accumulates in the 
liver during less than optimal vitamin A status. When retinyl ester is administered, holo-RBP 
is released into the serum. Serum retinol (or holo-RBP) is measured initially and then again 5 
hours following administration. A standard dose (1.6-3.5 [xmole [450-1000 |ig]) of retinol 
equivalents is given orally. Blood samples are taken at time 0 and 5 hours after the dose is 
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given. Serum concentration is measured by use of high-pressure liquid chromatography 
(HPLC), or by suitable spectrophotometric or colorimetric methods. The increase in serum 
retinol concentration, divided by the retinol concentration observed at 5 hours, is the RDR 
value, and is expressed as a percentage. Values ranging from 20 to 50% indicate a marginal 
status, while values >50% indicate deficiency. The RDR assay has been validated in humans 
using direct measures of liver vitamin A (24,25). 
While the RDR is an extremely useful tool in assessing marginal vitamin A status, the 
need to obtain two separate blood samples in a 5-hour interval can pose problems in the field. 
Also, the need to analyze two blood samples per individual increases time and money spent on 
each assessment. Possible error is also introduced into the analysis fi'om using two different 
samples for one calculation. 
Due to these limitations, a more refined dose response test was developed. 3,4-
Didehydroretinol (vitamin A2) was suggested as an indicator of vitamin A status when 
researchers observed that the ratio of A2 to retinol (Al) in serum was inversely related to the 
amount of vitamin A stored in the liver of rats (26,27). Similarly to Al, A2 binds to 
accumulated apo-RBP in the liver and is released as holo-RBP into the serum (28). 
Development of the new method, termed the modified relative dose response (MRDR), thus 
began in earnest (29,30). 
The MRDR assay involves giving an oral dose of A2 acetate (0.35 |imol/kg, or 100 
^g/kg body weight), dissolved in oil, and then taking a blood sample 5 hours later. At least 
200 |il of serum is necessary to perform the assay. The serum is then mixed with an equal 
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200 |j1 of serum is necessary to perform the assay. The serum is then mixed with an equal 
volume of ethanol and an aliquot of retinyl acetate (RAC) is used as an internal standard. 
Serum is then extracted using hexane, and the amount of A2, Al, and RAC are determined by 
use of HPLC. Standards of both Al and A2 are used to quantify the compounds, and a molar 
ratio of A2 to Al is calculated. MRDR values > 0.03 are indicative of marginal vitamin A 
status. This cutoff has been determined by comparison studies with the RDR and other 
vitamin A assessment techniques. While this cutoff level has been used in the United States, a 
value of >0.06 has been employed to indicate marginal vitamin A status in third-world 
countries, where the high incidence of protein-calorie malnutrition and other vitamin and 
mineral deficiencies exacerbate the situation (31). While these cutoff values seem arbitrary, 
they are based on the following observations; 1) MRDR ratios of healthy children and adults 
in the U.S. are < 0.03; 2) MRDR ratios of subjects in the U.S. that are >0.03 fall to values 
<0.03 in all instances following a dose of vitamin A; 3) MRDR ratios in healthy Indonesian 
children are usually <0.06; and 4) MRDR ratios in Indonesia that are >0.06 fall to values 
<0.06 following a dose of vitamin A (31). 
The MRDR has proven to be a valuable method for use in large field surveys. 
Synthesized A2 is stable in the dark for at least two years when kept < -20°C, for three 
months at 10°C, and for at least two weeks at room temperature. The assay itself requires 
only one blood sample, which can be frozen until analysis by HPLC can take place. HPLC 
systems and techniques are utilized world-wide, allowing relatively simple analysis of the 
serum samples. 
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Retinoid Toxicity 
Retinoids are essential for several biological processes, including growth and 
development, vision, reproduction, cellular differentiation, and pattern formation during 
embryogenesis. Deficiencies of vitamin A can negatively affect all of these biological 
processes. The recommended daily allowance (RDA) of vitamin A has been set at a level both 
to protect most healthy individuals against any of these negative effects and to provide a 
reserve for up to three months. Chronic doses at least ten times the RDA produce signs of 
excess vitamin A intake. These chronic toxicity signs include alopecia, ataxia, bone and 
muscle pain, cheilitis, conjunctivitis, headache, hepatotoxicity, hyperlipemia, hyperostosis, 
membrane dryness, pruritus, pseudotumor cerebri, various skin disorders, and visual 
impairment (32,33). Single doses of vitamin A exceeding 0.7 mmol in adults or 0.35 mmol in 
children produce acute toxicity signs including nausea, vomitting, headache, increased 
cerebrospinal pressure, vertigo, blurred vision, and muscular incoordination (32,33). 
Teratogenic effects from excess retinoid consumption occur at much lower doses than those 
producing acute toxicity symptoms, and at slightly lower doses than those producing chronic 
toxicity effects. Intake of retinoids early in pregnancy in amounts ten times the RDA have 
been shown to elicit strong teratogenic effects, including spontaneous abortions or significant 
malformations of the offspring (33-35). 
Retinoids produce a distinct pattern of teratological effects including embryolethality, 
dysmorphia of the central nervous system (microcephaly, exencephaly, hydrocephalus, 
encephaloceles, spina bifida), craniofacial defects (agnathia, micrognathia, anotia, microtia. 
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encephaloceles, spina bifida), craniofacial defects (agnathia, micrognathia, anotia, microtia, 
astomia, microstomia, cleft palate, teeth malformations), cardiovascular abnormalities 
(transposition of great vessels, ventribular septal defect, double outlet right ventricle, aortic 
arch irregularities), eye defects (anophthalmia, microphthalmia, exophthalmos, ablepharon), 
urogenital problems (missing kidneys) and poorly developed axial skeletal tissues. Most of 
these abnormalities are noted in all species tested (36). Permanent learning disabilities in the 
offspring occur fi-om sub-teratogenic doses administered prenatally (37). 
The teratogenic "potency" of retinoids may differ by several orders of magnitude and 
may be related to absorption, distribution, metabolic fate, placental permeability, or to 
interaction with embryonic intracellular receptors (38). Retinoids act as morphogens capable 
of altering embryonic cell migration, proliferation, and differentiation. An unsubstituted 
carboxylic acid group at the end of the tetraene chain (preferably in the dX\-trans configuration 
as in ^^\-trcms retinoic acid) seems to be a major structural requirement for the high 
teratogenic activity of retinoids in rodents (39). 
Retinoic acid can fulfill most of the physiologic and pharmacologic flinctions of 
retinol. It reverses symptoms of vitamin A deficiency except those related to vision and 
reproduction (40). Body tissues and cells in cultures possess the metabolic capability to 
convert ^-carotene and retinol into retinoic acid (41-44). Biological effects of retinoic acid 
may be mediated through its binding to nuclear retinoic acid receptors (45). Accumulated 
data fi"om nearly two decades has led many researchers to believe that the teratogenic effects 
of retinol are mediated by the extent of its metabolic conversion to retinoic acid. 
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The mechanisms by which retinoids exert their teratogenicity has been under intense 
investigation for several decades. For example, retinoic acid has a profound effect on 
patterning of the developing chick limb bud (46). A set of interactions involving the 
polarizing region, a small group of mesenchyme cells at the posterior margin of the limb bud, 
has been identified in the developing chick. The pattern of structures that develop across the 
antero-posterior axis of the limb bud is determined by a signal from the polarizing region 
acting on mesenchymal cells in the progress zone. The progress zone is a region of 
undifferentiated cells at the tip of the limb. Tickle et al. (46) found that grafts of the 
polarizing region to the anterior margin of the wing lead to mirror-image duplications of 
pattern. When retinoic acid is locally applied to the anterior margin, mirror-image duplicated 
patterns are also produced. The signaling induced by local application of retinoic acid and by 
the graft of polarizing region tissue is very similar. The effects are dose and position 
dependent. Extra digits can be produced by increasing retinoic acid concentration or by 
increasing the length of exposure. The changes that follow retinoic acid treatment appear to 
be mediated by mesenchymal cells (46,47). Retinoic acid either directly or indirectly specifies 
the position of mesenchymal cells in the bud, and the interaction of these cells with the those 
of the apical ridge, which defines morphologic development, is thereby determined. A signal 
is then produced that controls local cell proliferation in the bud mesenchyme. The acid of A2, 
namely 3,4-didehydroretinoic acid (ddRA), is also present in the developing chick wing bud, 
and is generated in situ fi-om retinol through an A2 intermediate (48). RA and ddRA possess 
equipotent morphogenetic properties in the chick limb. 
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Lopez and Carrasco (49) have concluded that retinoic acid affects limb development 
through its effect on neural crest cells, which are believed to establish positional cues in the 
brachial girdle for limb development. In a study nsmgXenopus laevis, these researchers 
showed that retinoic acid caused progressive truncation of anterior structures. The most 
severely affected embryos were devoid of eyes, nasal pits, forebrain, midbrain, and otic 
vesicles. These animals also possessed an enlargement of the hindbrain that reached the 
anterior end of the embryo. Spina bifida and deficiencies in elongation were also present. 
Besides these effects, retinoic acid produced malformations in the brachial arches and 
disorganization of the pronephros. Temporal and spatial distribution patterns of A1 and A2 
tended to coincide during Xenopus development (SO). 
Tickle (51) theorizes that retinoids may be important signaling substances in many 
parts of the vertebrate embryo where patterns of connective tissue are generated. Specific 
facial defects and patterning and morphogenesis of the facial primordium that gives rise to the 
upper beak in chick embryos are inhibited by the application of retinoic acid (S2). Local 
application of retinoic acid to the developing spine can induce the formation of additional 
vertebral structures (51). Wagner et al. (53) has shown that the floor plate of the neural tube 
can generate retinoic acid fi-om retinol. This may be the basis of the signaling that regulates 
some aspects of neuronal differentiation and axonal guidance. Recent studies have shown 
temporal and spatial patterns of expression of retinoic acid receptors and cellular binding 
proteins in the face, spine, and nervous system of vertebrate embryos (54-57). 
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Data accumulated from the analysis of expression patterns, ectopic expression studies, 
and gene disruption experiments strongly suggests a regulatory role for homeobox-containing 
genes during all stages of vertebrate morphogenesis (58). The plethora of studies that have 
tested the response of these genes to various retinoids have been useful in the identification of 
mechanisms by which retinoic acid associated dysmorphology occurs. However, a basic 
understanding of the partitioning of retinoids between maternal and embryonic/fetal 
compartments is also crucial in identifying mechanisms that may produce aberrant 
development. The developing embryo is dependent on the maternal circulation for vitamin A, 
since there is no de novo synthesis of retinol or retinoic acid. The flow of retinol across the 
placenta is bi-directional, but largely favors the fetus (59). Despite the wealth of study in this 
area, little is understood about how the transport and metabolism of retinoids is involved in 
teratogenic mechanisms. The function and importance of the various nuclear RAR and RXR 
receptors and the genes that they regulate in inducing terata also remain unclear. Increased 
knowledge in these areas may lead to the answers sought in determining mechanisms of 
retinoid-induced teratogenicity. 
Hypothesis 
The working hypothesis for the dissertation was that a single oral dose of d\\-trans 
t 
3,4-didehydroretinyl acetate (vitamin A2) in oil, when given at the dosage level of 
0.14 |imol/kg BW or 2.5 mg for use in the MRDR assay, is safe and effective for women in 
their third trimester of pregnancy. 
15 
While much data has been accumulated regarding teratogenic potency of certain 
retinoids (such as retinol and retinoic acid), no teratogenic data exists for A2. To test the 
issue of safety, experiments were designed to evaluate A2 in terms of induced toxicity, 
teratogenicity and embryolethality. Rat models work well for evaluation of these criteria, as 
rats are both sensitive and specific models for retinoid induced human teratogenicity. Timed-
pregnant Sprague-Dawley rats were dosed with a range of A2 on day 8.5 of gestation. Both 
dams and pups were evaluated. Comparisons were made between other groups of rats dosed 
with similar dose ranges of iW-trans retinyl acetate (Al) and ^\\-trans retinoic acid (RA), and 
to control rats, dosed only with the vehicle. Detailed findings related to this study can be 
found in Section 2. 
Because retinoids can also induce central nervous system (CNS) deficits in offspring, a 
second experiment was designed to evaluate the effects of A2 on CNS development in vivo. 
Similar to the first study, rats were dosed with a range of A2 on day 8.5 of gestation, and 
compared to control rats and groups of rats dosed with Al and RA. This study is presented in 
manuscript style in Section 3. 
The effectiveness of the use of A2 (as a part of the MRDR assay) to assess vitamin A 
status in pregnant women was also tested. Fifly-seven low-income pregnant women fi-om 
four different ethnic groups were assessed for marginal vitamin A status in the third trimester 
of pregnancy. Serum concentrations of P-carotene, a-carotene, lycopene, a-tocopherol, total 
cholesterol and retinol were also determined. The results of the study are presented in 
manuscript style in Section 4. 
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2. COMPARATIVE TERATOGENICITY AND METABOLISM OF THE ALL-
TRANS ISOMERS OF 3,4-DIDEHYDRORETINYL ACETATE, RETINYL 
ACETATE, AND RETINOIC ACID IN PREGNANT RATS 
A paper to be submitted to Teratology 
Pamela K. Duitsman and James A. Olson 
ABSTRACT 
The teratogenic potencies of the a\l-trans isomers of 3,4-didehydroretinyl acetate 
(A2), retinyl acetate (Al), and retinoic acid (RA) were compared. Groups of eight timed-
pregnant Sprague-Dawley rats were administered single equimolar doses (3.5-352 jimol/kg 
BW) of the retinoids orally in oil on day 8.5 of pregnancy. Al induced clear teratogenic 
effects at only the highest dose, and did not significantly increase embryolethality at any dose. 
Both RA and A2 were teratogenic and embryolethal at dose ranges of 35-352 nmol/kg BW. 
While gross terata did not appear at doses lower than 35 |amol/kg BW, embryolethality 
occurred with both A2 and RA at doses >11 |xmol/kg BW. Dams also exhibited toxic 
manifestations from doses of A2 and RA above 35 ^mol/kg BW. In the liver of dosed dams, 
the following effects were noted: 1) Liver concentrations of Al and A2 increased with the 
dose of Al and A2, respectively, 2) RA had little eflFect on Al except at the highest toxic 
dose, which induced an increase, and 3) A2 showed a sparing effect on Al. RA, although not 
detected in fetuses from dams treated with Al, was present in significant concentrations (0.5-
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4.1 nmol/g liver) in fetuses from dams treated with A2. The increased teratogenicity and 
embryolethality of A2 relative to A1 correlates with this enhanced concentration of fetal RA. 
Therefore, RA and A2 proved to be more toxic and teratogenic than Al, possibly due to 
differences in transport and metabolism among the retinoids. 
INTRODUCTION 
Physiological concentrations of retinoids are involved in regulating cell growth and 
development. At higher concentrations, retinoids possess teratogenic potential that is species 
dependent (Willhite et al., '89). Humans appear to be the most sensitive species on a body 
weight basis to retinoid-induced terata (Willhite and Book, '90). The structure of the retinoid 
is important in determining the embryotoxic and teratogenic potential of the compound 
(Willhite,'86). Retinoids that possess an acidic terminus group, e.g. 13-cis retinoic acid and 
iA-trans retinoic acid, generally have 2-3 fold more teratogenic potential in animals than the 
alcohol forms of vitamin A, e.g. retinol, and its fatty acyl esters. (Willhite, '90). 
3,4-Didehydroretinol (A2) differs from retinol (Al) in that it possesses a double bond 
at the 3,4 position (Figure 1). Vitamin A2 is a naturally occurring analogue of Al and is a 
common component of the food supply (Barua and Nayar, '66). The biological activity of 
A2 in stimulating the growth of rats is approximately 40% that of Al (Shantz and Binkman, 
'50; Sundaresan and Cama, '61; Howell et al., '67). 
A2 esters in foods are hydrolyzed to the alcohol (dehydroretinol) in the small intestine, 
absorbed in micellar form with other lipids, reesterified to the ester in the gut, transported on 
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chylomicra to the liver, and stored as vitamin A2 ester in the liver (Lederer and Rathman, '38; 
Goswami and Barua, '86; Tanumihardjo and Olson, '88; Farrer et al., '52; Henbest et al., '55). 
Vitamin A2 is released from the liver as a complex with retinol-binding protein (RBP) 
similarly to Al (Tanumihardjo et al. '87). 
A biological metabolite of vitamin A2, all-fraws-3,4-didehydroretinoic acid (ddRA) has 
been shown to have equivalent morphogenic properties to its vitamin A counterpart, dW-tram 
retinoic acid (RA) (Thaller and Eichele, '90). Further, ddRA was as biologically active as RA 
using several models of epithelial differentiation, although their metabolism differed depending 
on the cell type used (Torma et al., '94). However, the toxicity and teratogenicity of A2 in 
vivo has not been studied previously. We report here the relative teratogenicity of A2, Al, 
and RA in timed-pregnant Sprague-Dawley rats. 
MATERIALS AND METHODS 
All-/ra«s-3,4-didehydroretinyl acetate was synthesized from retinoic acid (Barua and 
Ghosh, '72) in our laboratories. The compound was purified twice on a column of 8% water-
deactivated alumina. Its purity, as judged by absorption at 350 nm, and determined by HPLC, 
was 99.9%, All-/ra»s-retinyl acetate and all-Zrawj-retinoic acid were obtained conmiercially 
(Sigma Chemical Co., St. Louis, MO, and BASF Corporation, NJ). 
Animals 
Timed-pregnant Sprague-Dawley rats (Holtzman, Madison, WI) were housed in 
accordance with Iowa State University and NIH guidelines in virus-free environments on a 
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light/dark cycle of 6 am to 6 pm. The animals were fed a diet of standard rat chow obtained 
from Harlan/Teklad, Madison, WI, containing 14.4 nmol retinol palmitate/g diet. 
Stucfy Protocol 
Each dam was administered single, equimolar oral doses of the retinoids (3.5-352 
|imol/kg body weight) in approximately 250 |il com oil, pipetted directly into the mouth of 
each animal by using a Gilson positive-displacement pipette (Rainin Instruments, Wobum, 
MA) on day 8.5 of pregnancy. Control animals received com oil only. Gestation was 
intermpted on day 19.5 by cervical section of etherized dams. Uterine horns were examined, 
implantation sites counted, and fetuses removed. Maternal semm was collected by cardiac 
puncture and matemal livers were excised. Fetuses were weighed, measured, and 
photographed. Thereafter fetal livers were excised, blotted on humid filter paper and frozen 
at-20°C. 
Retinoid Extraction and Analysis 
All operations were carried out under yellow light. Extraction of matemal and fetal 
livers (0.5 g) was accomplished by the method of Barua and Olson ('89). The tissue was 
ground with 1.5 g anhydrous sodium sulfate exhaustively by use of a pestle and mortar. 
Methylene dichloride (5 volumes) was added along with internal standard (1.4 |ag retinyl 
acetate; 150 |il), and samples were ground further. Methylene dichloride was filtered, and 
extracts were pooled and mixed. An aliquot (1 ml) of the extract was evaporated under 
argon, and the residue redissolved in 200 |j1 of methanol;methylene dichloride (1;1 v/v) for 
analysis by HPLC. 
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Extraction of retinoids from the serum of dams was achieved by treating serum (200 
^il), with 100% ethanol (400 |il), 10% acetic acid in water (20 |il), and ethyl acetate (400 |a1). 
Internal standard (1.4 |ag retinyl acetate; 250 |al) was added and the mixture was subjected to 
further extraction by use of hexane (2 X) (Barua and Olson, '89). The extracts were washed, 
pooled, dried under argon, and resuspended in 100 |jl methanolimethylene dichloride (1:1 v/v) 
for injection onto the HPLC column. 
Each sample was applied to a 5 |xm C18 Waters Resolve reversed-phase column by 
use of a WISP autoinjector (Waters, Milford, MA) using the method described by Barua 
('90). A Waters 996 photo-diode array (PDA) detector monitored absorbance at 325 nm for 
retinoic acid, retinol, and retinyl esters, and at 350 nm for 3,4-didehydroretinol and its esters. 
Two Waters 510 pumps were set at a flow rate of 1.2 ml/min, and operated by use of a 
Waters automated gradient controller. A gradient solvent system consisted of a linear 
gradient of solvent A (methanol-water, 68:32, v/v) to solvent B (methanol-methylene 
dichloride, 4:1, v/v) over 20 min. Solvent B was run for 10 min more, at which time the 
gradient was changed to initial conditions over a 5-min period. The column is equilibrated for 
10 min prior to the next injection. Retention times for retinoic acid, 3,4-didehydroretinol, 
retinol, 3,4-didehydroretinyl acetate, retinyl acetate, 3,4-didehydroretinyl palmitate, and retinyl 
palmitate were 12, 18, 21, 24, 25, 31 and 32 min, respectively (Figure 2). The Millennium 
2010 software version 1.2, which was developed by Waters for use with their 996 PDA 
detector, performed data acquisition, processing, and management of chromatographic 
information. All data were acquired and stored in three-dimensional mode, which allowed 
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detailed examination of selected spectra, integration of peak areas, and assessment of the 
purity of compounds. 
Statistics 
Least squared means, standard errors, means, standard deviations, Student's t-tests 
and P values were determined by use of general linear model procedures of the Statistical 
Analysis System, version 6.07, Gary, NC. 
RESULTS 
Toxic effects on dams 
Dams dosed with 3.5 |xmol/kg BW of both RA and A1 were significantly younger and 
smaller than other animals used in this study. Throughout the experiment, we perceived that 
these animals showed a higher level of stress than older animals. Thus, the anomalous data 
acquired from these two groups may well be a reflection of the animals response to pregnancy 
rather than to the compounds dosed. 
Dams dosed with either 352 |imol/kg RA or A2 showed overt retinoid toxicity, 
exhibited by loss of hair and hair discoloration. Decreased weight gain which was noted at 
doses >35 |imol/kg A2 and >113 nmol/kg RA, appeared to be a more sensitive indicator of 
dam toxicity for both retinoids. 
Fetal resorption 
As sununarized in Table 1, control animals experienced no resorption. This is unusual, 
since average background embryolethality in rodents has been reported to be approximately 
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4% (Manson, '86). In similar earlier studies in our laboratory, we found 1.8% resorption in 
control Sprague-Dawley rats (Gunning et al., '93). RA at 352 |imol/kg caused 100% 
resorption, which decreased in a dose-dependent manner to 3.6% at 3.5 |amol/kg. All doses 
of Al gave similar resorption rates of approximately 4%, although others have reported dose-
dependent embryolethality in Wistar rats (Langman and Welch, '66). Interestingly, the 
vitamin A2 dose response curve for resorption was non-linear, with most resorption occurring 
at the 35 |imol/kg dose. 
Terata 
RA was the most teratogenic compound, increasing terata significantly (p < 0.0001) at 
113 lamol/kg. Of the terata present, 75% consisted of exencephaly, 17% abdominal 
protrusion, 8% microcephaly, and 8% bulging crown. No terata was evident for doses of RA 
£ 35 |imol/kg. A2 at 352 |Amol/kg induced 5% terata, compared with 3% for Al. Further, 
the type and extent of terata for the A2 group were more profound than were those caused by 
Al. Fetuses exhibiting terata at this dose of A2 had bulging crowns (60%) and exencephaly 
(40%). One stillborn fetus of the A2-treated dams exhibited gross terata, with complete 
craniofacial malformation, exencephaly, and protrusion of the abdomen. Terata apparent from 
Al at the same dose included eye abnormalities (25%) and bulging crowns (75%). Both A2 
and Al also induced terata at the 113 |imol/kg dose; A2 primarily produced malformations of 
craniofacial features, and Al generated slight cranial bulges. No terata were evident for doses 
^ 35 |j,mol/kg of Al or A2. 
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Pup length and weight 
Gh-owth of the fetus was significantly reduced by doses of RA >11 |imol/lcg. While 
A1 had no effect on pup length or weight, A2 at lower doses (3.5-11 |amol/kg) somewhat 
surprisingly tended to reduce pup weight but not length. 
Maternal liver 
Liver weight/body weight ratios and mean concentrations of retinoids recovered from 
maternal livers are summarized in Table 2. Liver concentrations of A1 and A2 expectedly 
increased with the dose of A1 and A2, respectively. RA had little effect on A1 except at the 
highest toxic dose, which induced an increase of Al, while A2 showed a sparing effect on A1 
at higher doses. RA was detected only in the livers of dams treated with 35 fimol/kg of A2. 
Fetal liver 
Mean concentrations of total Al in fetal livers tended to decrease with increases in 
dosing, as summarized in Table 3. A2 was detected in fetal livers from animals dosed with 
11-352 |amol/kg A2 with individual values ranging from 0.3-3.9 nmol/g liver. RA was 
detected in fetal livers from dams treated with the 3.5 and 113 |imol/kg of RA and 11-352 
fimol/kg of A2. RA values in individual fetal livers in the RA and A2-treated groups ranged 
from 0-2.2 nmol/g liver and 0-4.1 nmol/g liver, respectively. RA was not detected in fetal 
livers from dams treated with any concentration of Al. Furthermore, no A2 was found in 
fetal livers from dams dosed with any concentration of Al. 
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DISCUSSION 
The maternal toxicity evident in the present study (decrease in weight gain, hair loss, 
and hair discoloration) is consistent with classic toxic manifestations of retinoid 
administration. Corroborative of previous studies, RA produced well defined patterns of 
terata and embryolethality in a dose-dependent manner (Gunning et al., '93; Nau et al. '94). 
A1 showed teratogenic effects only at the highest dose tested. 
Although A2 induced terata also followed a linear dose-response curve, A2 induced 
embryolethality did not. Embryolethality for A2 at 35 lamol/kg BW was nearly nine times that 
observed at 352 |amol/kg BW. To validate this finding, the A2 dose at 35 |xmol/kg was 
repeated, in a different group of eight pregnant dams. Similar results were obtained. 
The recovery of retinoids from dam livers points to a possible difference in the 
metabolism of Al and A2 (Table 2). A2 dosed animals showed a dose-response effect for A2 
found in tissues. Likewise, liver storage of Al increased in a dose-response manner in Al 
dosed animals. Compared to control animals, A2 was effective in sparing liver Al in livers of 
animals dosed at 35 |imol/kg BW A2. However, the storage of liver Al in animals dosed at 
35 jimolkg BW A2 was roughly twice that of dams treated with the larger dose of 352 
^mol/kg BW A2. In fact, for all three compounds administered at the 35 ^imol/kg BW dosage 
level, concentrations of Al were greatest in the livers of A2 dosed animals. An additional 
curious finding was the exclusive recovery of RA from the livers of dams dosed with A2 at 35 
^mol/kg BW. The fact that RA was not present in tissues of RA dosed animals is not 
surprising, since tissues were analyzed eleven days after RA was administered. RA is known 
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to be metabolized quickly, and its inactive metabolites are excreted in the urine and feces 
within seven days (Roberts and DeLuca, '67). The absence of RA in the livers of A1 dosed 
animals intimates a difference in the catabolism of A1 versus A2. The unusual ability of A2 at 
35 |j.mol/lcg BW to increase liver concentrations of A1 and RA correlates with the increased 
embryolethality seen at this dose of A2. 
In fetal liver tissues, A1 concentrations did not follow a dose-response curve. Indeed, 
whereas RA dosing had no consistent effect, increasing doses of A1 and A2 were associated 
with lower total A1 values. In contrast, A2 appears in fetal livers of A2 dosed animals in a 
dose dependent manner. Interestingly, RA is found in the fetal livers of all A2 dosed animals, 
with the exception of the lowest A2 dose, but in none of the A1 dosed animals. Even when 
RA was administered, fetal liver RA at 19.5 days was less than in A2-dosed animals. RA 
accumulation from an A2 dose was maximal at two mid-range levels of A2 (11 and 113 
^mcl/kg BW). Due to the high incidence of embryolethality at the 35 ^imol/kg BW dose of 
A2, only one fetal liver was available for analysis of RA concentration. While this liver did 
contain RA, the RA concentration was not reported since one sample cannot be considered 
representative of the entire group. 
Both A1 and A2 seem to be absorbed and stored well, since both compounds increase 
in the liver tissues of dams in a dose-dependent manner. However, the accumulation of A1 in 
fetal livers from a dose of A1 appears to decrease with increasing levels of A1 administered. 
Conversely, A2 increases in a dose-dependent manner in fetal tissues. Thus, the metabolic 
regulation and transport of A1 vs. A2 in the pregnant rodent seem to be different. The 
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detection of RA in the livers of A2 dosed dams and fetuses correlates well with the 
unconventional response curve of A2 relative to embryolethality. Thus, the increased 
teratogenicity and embryolethality of A2 relative to that of A1 may be due to the presence of 
RA in tissues of A2 dosed animals. We hypothesize that at high concentrations, A2 may 
inhibit conversion of inactive precursors to RA, whereas at slightly lower concentrations, A2 
may inhibit catabolism of RA to inactive products. Thus, as the concentration of A2 in the 
fetus increases in a dose dependent manner, the steady-state concentration of RA will first rise 
and then fall (Figure 3). 
While our data support the above hypothesis, other explanations exist. Retinoid 
nuclear receptor proteins (RARs and RXRs) are specifically activated by retinoids in a manner 
unique to each ligand. Consequently, distinct pathways may be initiated by different retinoids, 
leading to specific developmental, toxic and/or teratogenic effects. 3,4-Didehydroretinoic 
acid (ddRA) has been shown to be as potent as RA at invoking digit duplications in the chick 
wing bud (Thaller and Eichele, '90), and the nuclear receptor protein binding profiles for 
ddRA and for RA in vitro are very similar (Torma et al., '94). Nonetheless, it is conceivable 
that differences in the metabolism of Al, A2 and their corresponding acids may well lead to 
differential activation of retinoid nuclear receptors, and thereby account for different toxic and 
teratogenic effects. Comparative pharmacokinetic studies of Al and A2 in the pregnant 
animal and their relative effects on specific reactions in RA metabolism may clarify the unusual 
outcome data reported here. 
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Figure 1. Formulas of the ^\-trans forms of retinol (Al), 3,4-didehydroretinol (A2), and 
retinoic acid (RA). 
35 
0.30 
0.25 
0.20 
§ 
0.15 
0.10 
O.OS 
0.00-
25!O6 5.00 10.00 30.00 35.00 
Minut«s 
Figure 2. Chromatogram obtained with reversed-phase gradient HPLC of a standard mixture 
of retinoids. 
Table 1. Pregnancy outcome for rats administered 2\\-tram retinoids on day 8.S of gestation 
Treatment Dose in 
^mol/kg BW 
Number of 
Litters 
Implantation 
Sites 
Stillbirths Percent 
Resorption 
Percent 
Terata 
Mean Pup 
Weight (g) 
(Mean±SEM) 
Mean Pup 
Length (cm) 
(Mean±SEM) 
None 0 10 126 0 0 0 2.61±0.09 3.15±0.05 
(control) 
RA 3.5 7 84 0 3.6 0 2.45±0.11 3.29±0.06 
11 6 81 0 7.4 0 2.18±0.12' 3.0910.07 
35 7 98 0 6.1 0 2.34±0.1l' 3.3410.06' 
113 5 79 1 52.0" 15.0" 1.66±0.13* 2.8710.07^ 
352 7 88 
-
lOO.O" — 
- -
A1 3.5 5 50 0 4.0 0 2.34±0.13 3.2410.07 
11 6 75 0 3.0 0 2.43db0.12 3.3510.07 
35 8 96 0 4.2 0 2.30±0.10 3.2710.06 
113 10 103 0 5.8 1 2.53±0.09 3.2210.05 
352 9 91 0 3.3 3.3 2.45±0.09 3.1310.05 
A2 3.5 7 96 0 1.0 0 2.17±0.11^ 3.0910.06 
11 9 108 0 6.5 0 2.21±0.09^ 3,1610.05 
35 6 53 0 22.6^ 0 2.55±0.12 3.2210.06 
113 8 88 1 11.4 2.3 2.60±0.11 3.2710.06 
352 9 78 1 2.6 5.1 2.47±0.94 3.1510.05 
'Significantly different from control (p^0.05). 
^Significantly different from control (p^O.Ol). 
^Significantly different from control (piSO.OOl). 
''Significantly different from control (p^O.OOOl). 
Table 2. Liver to body weight ratios, and means ± standard deviations of retinoids recovered from liver 
tissues of dams (n=3). 
Treatment Dose in Liver/Body Total A1 Total A2 ^W-trans RA 
lamol/kg BW Weight Ratios (%) (nmol/g liver) (umol/g liver) (|imol/g liver) 
None (control) 0 3.97+0.07 0.68+0.04 ND ND 
RA 3.5 4.11±0.10 2.1810.59^ ND ND 
11 4.1910.10 0.4210.06 ND ND 
35 4.26±0.09^ 0.30+0.09 ND ND 
113 4.27±0.1l' 0.4210.10 ND ND 
352 3.62±0.09^ 0.7910.15 ND ND 
A1 3.5 4.37±0.11^ 0.7110.49 ND ND 
11 3.95±0.10 0.5710.04 ND ND 
35 4.0610.08 1.5210.40 0.00110.001 ND 
113 4.1910.07 1.6710.15' 0.00110.001 ND 
352 4.1210.08 2.37+0.13" 0.00310.001 ND 
A2 3.5 4.0210.09 0.61+0.02 0.01+0.003 ND 
11 4.1610.08 0.3510.01 0.0310.01 ND 
35 3.7710.10 1.8310.97' 0.3110.12" 0.00210.003^ 
113 4.1010.09 1.0110.94 0.6410.13'' ND 
352 4.15+0.08 1.06+0.50 l.Ol+O.ll" ND 
ND = not detected 
* Significantly different from control (p<0.05). 
^Significantly different from control (p<0.01). 
^Significantly different from control (p<0.001). 
""significantly different from conrol (p<0.0001). 
Table 3. Mean concentrations (+ standard deviations) of retinoids recovered from liver tissues 
of fetuses on day 19.5 of gestation (n=9). 
Treatment Dose in Total A1 Total A2 all-trans RA 
Hmol/kg BW (nmol/g liver) (nmol/g liver) (nmol/g liver) 
None (control) 0 8.7±1.1 ND ND 
RA 3.5 16.1±1.6^ ND 0.2310.33 
11 9.0±1.0 ND ND 
35 9.810.9 ND ND 
113 15.7±3.2^ ND 0.7311.03' 
352 ~ ~ — 
A1 3.5 21.4±0.7* ND ND 
11 15.1±1.3^ ND ND 
35 10.7±l.l' ND ND 
113 13.6+0.7 ND ND 
352 11.4±3.0 ND ND 
A2 3.5 14.6+2.6^ ND ND 
11 9.8±1.3 0.40±0.03^ 1.1210.44^ 
35 8.8±1.3 0.49±0.11^ +* 
113 11.2+1.3 3.36+0.32" 4.0710.035" 
352 7.3+1.1 3.5210.39" 0.5410.005 
ND = not detected ''Significantly different from control (p<0.0001). 
'significantly different from control (p<0.05). '''Only one animal was available for this data point. 
^Significantly different from control (p<0.01). RA was found, but the single value cannot 
^Significantly different from control (p<0.001). be considered as representative of a group. 
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Figure 3. Hypothesized effects of A2 on the formation and synthesis of RA in vivo. 
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3. EFFECTS OF THE PRENATAL ADMINISTRATION OF THE AU^TRANS 
ISOMERS OF 3,4-Dn)EHYDRORETINYL ACETATE, RETINYL ACETATE, AND 
RETINOIC ACID ON THE DEVELOPMENT AND SPONTANEOUS MOTOR 
BEHAVIORAL PATTERNS OF RATS 
A paper to be submitted to Neurotoxicology and Teratology 
P. K. Duitsman, D.L. Hopper, and J. A. Olson 
ABSTRACT 
The effects of prenatal administration of the all-trans isomers of 3,4-didehydroretinyl acetate 
(A2), retinyl acetate (Al), and retinoic acid (RA) on pup development and spontaneous motor 
behavior were evaluated at six weeks postnatally. Grroups of 20 timed-pregnant Sprague-
Dawley rats were administered single equimolar doses (ranging from 1-11 |xmol/kg BW A2 
and RA; and 3.5-35 |imol/kg BW Al/kg BW) orally in com oil on day 8.5 of pregnancy. 
Dams of control pups received vehicle only. Live birth rates were reduced in groups receiving 
A2, though no external abnormalities were observed, regardless of the treatment received. 
Pups from treated dams were paired with pups from control dams and tested using a computer 
pattern recognition system (RAPID). Significant changes in motor behavior patterns were 
evident in males whose dams were dosed with 3.5 ^imol A2/kg BW and in females whose 
dams received 1 lamol A2/kg BW, but, surprisingly, not at 3 to 10-fold higher doses of A2. 
No significant behavioral effects were seen in males in either the Al or RA groups at the 
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doses used. The lack of a dose-response relationship in the behavioral effects of A2, which 
differs from all other retinoids tested, is both interesting and puzzling. 
INTRODUCTION 
The teratogenic potential of retinoids, in terms of gross malformations, embryolethality 
and overall development of the fetus, has received much attention. Maternal administration of 
vitamin A-related compounds has also been shown to effect central nervous system (CNS) 
function leading to learned behavior dysfunction in rodents (2). Endpoints for classical 
teratology studies have included fetal death, malformations and growth retardation, which are 
easily quantified. However, valid methods of measurement of functional deficits in the 
offspring have not been widely agreed upon. The effects of retinoids on behavioral outcomes 
are commonly measured by using learned behavior as the endpoint (2). Reported retinoid 
induced behavioral changes include alterations in righting reflexes, reflex development, 
response to shock avoidance, performance in Biel maze, puzzle box maze, running wheel, and 
other pre- and post-weaning activities (4,17,22-24). Doses of retinoids given on day 8.5 of 
gestation which have produced alterations in behavior have ranged from 11-90 |amol//kg BW 
(1,3,4,13,17,22,23). Recently, automated methods for evaluating spontaneous motor 
behavior have been shown to be sensitive, reliable and reproducible (7,9,11). 
The teratogenic potential of A2 has recently been shown to be slightly greater than 
that of Al. Furthermore, the A2 dose response curve for inducing embryolethality is non­
linear, compared to linear responses to both Al and RA (unpublished results, Duitsman and 
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Olson, 1995). While incidence of malformation, embryolethality and growth development has 
been evaluated for these retinoids, no information is available on the behavioral effects of A2 
on offspring as related to A1 and RA. 
The goals for the present study were to determine: 1) if spontaneous behavioral 
changes could be observed, using a sophisticated computer pattern recognition system, in six 
week old rat offspring from dams dosed Avith A2, A1 or RA on day 8.5 of gestation; and 2) if 
postnatal behavioral effects in males are different from those in females dosed prenatally with 
A2. 
METHODS 
Animals and Dosing 
A total of 126 timed-pregnant Sprague-Dawley rats were purchased from Harlan 
Sprague-Dawley, Holtzman Laboratory Animals, Madison, WI. All dams were housed 
individually in hanging wire cages in accordance with Iowa State University and NIH 
guidelines and maintained on a 12 hr. day/night light cycle (0700-1900) with food (Teklad 
Premier, Teklad Inc., Madison, Wisconsin) and water available ad libitum. 
All-/>'awj-3,4-didehydroretinyl acetate was synthesized in our laboratories. P^\-trans-
retinyl acetate and all-/ra«s-retinoic acid were obtained commercially (Sigma Chemical Co., 
St. Louis, MO and BASF Corporation, NJ). Each dam was administered single, equimolar 
oral doses of the retinoids (1-11 |imol/kg BW for A2 and RA; and 3.5-35 |.imol/kg BW for 
Al), pipetted directly into the mouth of each animal by using a Gilson positive-displacement 
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pipette (Rainin Instruments, Wobum, MA) on day 8.5 of pregnancy. Control animals received 
vehicle only. Pups were sexed and culled to eight pups per litter upon parturition. Pups were 
weaned at 22 days of age and housed separately in hanging wire cages, according to the same 
protocol mentioned previously for dams. 
Measurement of Spontaneous Motor Behavior Patterns 
The Rodent Activity Pattern Identification Device (RAPED) system for measuring 
motor behavior patterns has been described previously (8,9). The observation chamber 
consisted of a trapezoidal Plexiglas chamber split into two compartments, and divided by a 
second plate of Plexiglas with six drilled holes to allow paired rats to smell one another. A 
control rat was placed in one side of the chamber, while a treated rat occupied the other side. 
The animals were observed simultaneously by two video cameras, one oriented horizontally 
and the other oriented vertically. Images were taken at one frame per second from each 
camera for a total of 900 observations per rat over a IS minute period. 
Classification of Activities 
The video signals were transferred to a microcomputer for data recording and then to 
a Digital Equipment Corporation (DEC) 3100 workstation for subsequent pattern analysis and 
behavioral classification of the data. Two distinct taxonomies were used to classify behaviors: 
molecular (single act) and a molar (coordinated action) taxonomies. Sackett (20) defines 
"molecular taxonomy" as a system that "defines categories as closely as possible to specific 
motor actions, postures, gestures, facial expressions, objects, and directions of action" and 
"molar taxonomies" as a "combination of a number of actions, directions, and objects of 
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behavior into generic classes defined by the function or outcome of the motor action '^. 
Behavioral acts in both the molecular and molar taxonomies are listed in Table 1 and defined 
in Table 2. Further details of the testing environment, procedure, taxonomies used, and 
definitions of behavioral acts have been previously described (8,9). Behaviors are classified 
using the molecular and molar taxonomies, and the behavioral acts in each taxonomy are 
analyzed in terms of number of initiations, total time, time distribution and time sequence. 
Evaluation of Behavior 
Six-week old pups were observed using the RAPID system under red light. For each 
dosage level of each compound, twenty pairs of six-week old pups were analyzed, with each 
pair consisting of one treated and one control animal. All animals tested were naive to the 
environment. 
During the period preceding observation, all rats were housed exclusively under 
diurnal reversal conditions, so that they were exposed only to red light fi"om 0700 to 1900 
hours, and only to white light during the remaining 12 hours. Tests were conducted during 
the period 0900 to 1700 hours under red light. Three measures of spontaneous motor 
behavior, which are known to contain independent information about CNS control of motor 
output, were taken. All three were necessary, because for any particular act, significant 
changes can occur in any one of these parameters for that act while the others remain 
unchanged (9). These three measures are a calculation of behavioral initiations, behavioral 
total time, and calculation of time distribution and time sequence of acts. 
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Behavioral Initiations. Frames in which a particular act began were totaled for the 
observation period. A mean for each initiated act for both control and treated animals was 
determined. Student's t-test, with a p<O.OS was used to indicate statistical significant 
differences between the control and treated groups. 
Behavioral Total Time. The frame in which a behavior is initiated, and the number of 
firames for which that behavior is continued, are totaled for the entire observation period. 
Mean total times were determined, and Student's t tests, with a p<0.05, were used to indicate 
statistical significance. 
Time Distribution and Time Sequence. Methods for the analysis of a behavioral act 
have been adapted from statistical research devoted to analysis of spatial point patterns (5,19). 
The original spatial techniques are adapted by replacing distance with time. The methods have 
been previously described (14) and result in a function Ka(t) which can be used to analyze the 
time distribution of a behavioral act, "stand" for example, or in a related form Kap(t) to 
analyze the time sequence of two behavioral acts, for example "stand" and "sit". These 
methods have been used extensively in prior publications and will not be described in detail 
here. The time distribution of a specific behavioral act (e.g., "sit", "rear") or sequences of 
specific behavioral acts ("sit" with "rear") were calculated using equations for K(t) (14). For 
a time sequence, "sit" with "rear" for example, the time interval for K(t) occurrence begins 
with the first act and ends with the second act. So the K functions for the sequences of "sit" 
with "rear" and the opposite pairing "rear" with "sit" should not be identical and, if one is 
changed by the treatment, this is not necessarily true for the opposite pairing. In addition, K 
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functions were determined for combined acts (e.g., "attention" or "attention/groom") and 
sequences of combined acts (e.g., "attention" with "explore" or "attention/explore" with 
"groom/attention") as described by Keman et al. (9). 
The function K(t) was calculated for each behavioral time distribution or time 
sequence, and then AK(t) (the difference between K(t) for the exposed animals and matching 
controls of a particular data set) was calculated for eight time points (2, 5, 10,20, 30,45,100 
and 200 s). The bootstrap technique was used to estimate the standard deviation in this 
measure (9). The ad hoc criteria for the significance in the change in a particular time 
distribution or time sequence between treated rats and matching controls have been described 
(9). Whenever any time distribution or sequence involved a behavioral act which had an 
average number of initiations (per animal) less than 10 in either the control or experimental 
group, the K(t) values were not determined. 
When the K function for the treated group is smaller than that for the control group, 
AK(t), as defined above, is positive; the initiations of that act or pair of joint acts are more 
dispersed in the treated group than in the controls. If the initiations for the treated group are 
more clustered than in the controls, the AK(t) value will be negative. For those K functions 
which are changed by the experimental manipulation, a consistent pattern of more dispersed 
initiations, positive AK(t) values, has in past experiments been associated with agents known 
to produce hyperactivity (15), and a pattern of more clustered initiations, negative AK(t) 
values, has been associated Avith agents known to produce hypoactivity (10). 
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The RAPED system, for any given data set, results in up to 154 measures which may 
each be "changed" or "not changed". Due to the restriction, referred to above, on the average 
number of initiations of any behavioral act when calculating K(t), the usual number of 
measures in a typical data set will range from 95 to 126. If the treatment has induced highly 
stereotypic behavior, the number of measures for that data set may even be considerably less 
than 95, With this multitude of measures, the first question to be faced is "has the treatment 
changed the overall behavior of the animals?". Recently Keman and Meeker (11) have 
introduced an ad hoc statistic, termed RS, which addresses exactly this question. Each of 
these 154 measures (or more typically, depending on experimental outcome, 95 to 126 
measures) can be placed in a vector X that has dimensionality equal to the number of 
measures. Given such a highly dimensional "signal" vector, there is not a probability model to 
describe the correlational structure among these observed measures. Thus there is no obvious 
"best way" to combine X into an overall statistic to test for behavioral change. However, for 
each measure in X, there exists a criterion to determine whether that particular measure was 
individually "significantly changed." Using these criteria, the vector X can be mapped into a 
binary vector, call it Y, with the same dimensionality but where all elements are either 0 (no 
statistically significant change) or 1 (a statistically significant change). It is useful to recall 
that part of the information in Y comes from the analysis of the molecular acts and part from 
the analysis of the molar acts. Differentiating these two parts as being due to Yi, from the 
molecular acts, and Y2 from the molar acts, Yi will have a maximum dimension of 106, and 
Y2, a maximum of 48. Yi and Y2 will then partition the entire space of the original Y. This 
partition is used because every observation of the animals is included in the data used to 
determine both Yi and Y2. As an example, the molecular acts for the major body positions 
"walk" and "rear" and the modifier acts "turn" and "snifF' are all included in the molar act 
"explore". A drug, particularly if it induces hyper- or hypoactivity may change the acts 
"walk", "rear", "turn", and /or "snifF', or its effects may only be observable when all these are 
combined into the act "explore". The changes in "walk", "rear", "turn", and "sniff' are 
contained in Yi, while any change in "explore" is contained in Y2. Let Si denote the sum of 
all nonzero elements of Yi (remembering that all elements are either 0 or 1) and let Ti denote 
the number of elements in Yi. Y2, S2 and T2 are similarly defined. The conditions of the 
actual data analysis are such that Ti is always greater than T2. Since the original information 
is, in some sense, summarized in each of these subvectors, it is of interest to use a statistic in 
which the two are approximately evenly weighted. This can be done by defining the ratio RS 
In their Monte Carlo study of data from the RAPED system, Keman and Meeker (11) found 
that, for an experiment or data set having 20 pairs of animals, an RS value greater than 0.138 
corresponded to a probability of <0.001 for the control and treatment group to satisfy the null 
hypothesis. Keman and Meeker (11) also found, again for 20 pairs of rats, that an RS value 
of less than 0.067 corresponded to a probability of >0.10 for the control and treated groups to 
satisfy the null hypothesis. This single statistic, which encompasses all of the data produced in 
as; 
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the study of a particular exposure, indicates whether behavior is changed and at what 
confidence level that conclusion can be based. It is especially useful in distinguishing low level 
effects fi-om noise. The RS statistic is an overall indication of change. When a RS value 
indicates a change in behavior, the details of which measures are changed and how they are 
changed should be examined, since such an examination often provides important information 
regarding the specific nature of the behavioral change. With as many as 154 measures for 
each treatment condition, ordinarily a few of the measures will be described as "changed" 
when in fact one is only observing the result of statistical chance. We use the RS statistic to 
decide when observations actually correspond to a statistically significant behavioral change. 
For completeness however, we will present all measures which are marked as "changed" even 
in those treatment groups where we conclude these "changes" correspond to "statistical 
noise" based on the RS value for the treatment group. 
RESULTS 
Physiological Data 
Live birth rates were reduced for litters of animals dosed with A2 (Table 3). Live 
births were 87%, 91%, and 96% for groups dosed with A2 at 11,3.5, and 1 iimol/kg BW, 
respectively. A minor sex effect for live birth rates was evident, with females slightly more 
vulnerable than males (Table 3). All remaining treatment groups, including control groups, 
had a 100% live birth rate. Weight gain was reduced in male rats dosed at 3.5 |.imol/kg BW 
A2 and for male rats at all dose levels of RA, though the differences were not statistically 
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significant fi-om controls (Table 3). Growth of rats fi-om the A1 35 |imol/kg BW group was 
slightly less than that of control animals, possibly due to a slight teratological effect of A1 at 
this dose on development. However, animals in groups dosed with A1 fi'om 3.S-11 |amol/kg 
BW experienced increased growth, with weight gain significantly increased (p<0.01) at the 11 
^mol/kg BW dose when compared to control animals. 
Behavioral Data 
RS values for each of the 12 treatments are presented in Table 4. The RS statistic 
indicates that A1 and RA, at the doses administered on day 8.5 of gestation, do not 
significantly alter motor behavior of offspring tested six weeks postnatally. However, the RS 
statistic indicates that A2 produced significantly altered postnatal motor behavior in both male 
and female rats at six weeks of age. Male animals fi'om the A2 dosed groups experienced 
profound behavioral changes at the mid-range dose of 3.5 |imol/kg BW (RS = 0.220, 
p<0.001). A2 also produced extreme modification of behavior in female animals dosed at the 
lowest level of 1 ^imol/kg BW (RS = 0.825, p<0.001). Surprisingly, the higher and lower 
doses of A2 given to males and the higher two doses of A2 given to females showed no 
behavioral consequences. 
Table 5 summarizes behavioral modification at six weeks of age following prenatal 
exposure to A1 and RA. Neither compound produced significant behavioral effects on the 
offspring in regard to frequency, duration, time sequence, or time duration of acts for either 
major body position or modifying acts. Table 6 summarizes behavioral modification at six 
weeks of age following prenatal exposure to A2. The total number of changes in behavior 
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was greatly increased for female animals dosed with A2 at 1 |imol/kg and male animals dosed 
with A2 at 3.5 |imol/kg, but not at any other doses. A significant amount of disruption 
appeared in the time sequence of behaviors for the female animals. The comparative patterns, 
relative to controls, of behaviors between female animals dosed with A2 at 1 ^mol/kg BW and 
male animals dosed with 3.S |amol/kg BW A2 are given in Tables 7 and 8. 
DISCUSSION 
Physiological Data 
Toxic effects of prenatal administration of retinoids include birth defects, reduced live 
birth rates and reduction in growth and development of the offspring (6,12,13,16,22). While 
no defects were noted for the offspring in this study, reductions in both growth and 
development and live birth rates were observed. Growth reduction was observed in male rats 
dosed at 3.5 jimol/kg BW A2 and for male rats at all dose levels of RA, although the 
reductions were not significantly different from control animals. Reduction of growth and 
development due to prenatal administration of RA is well documented (6,16). While prenatal 
administration of A2 has not been shown to reduce growth and development at these levels, 
reduction of growth for male rats dosed with 3.5 fimol/kg BW A2 coincided with behavioral 
effects seen in animals from this group. Live births were reduced 13%, 9%, and 4% for 
groups dosed with A2 at 11, 3.5, and 1 ^imol/kg BW, respectively. While the effect of A2 to 
reduce live birth rates has not been previously reported, A2 has been shown to induce 
embryolethality at doses ^1 |amol/kg BW by an as yet undetermined mechanism (unpublished 
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results, Duitsman and Olson). Animals dosed with A1 and RA prenatally experienced normal 
birth outcomes, with 100% live birth rates for all litters. The increased teratogenic potency of 
A2 in regards to live birth rates corroborates our behavioral data, which indicates that A2, 
while not A1 or RA, induces behavioral changes when given prenatally. 
Behavioral Data 
Retinoids administered prenatally have also been reported to aflfect the ability of 
offspring to perform learned tasks and tasks requiring motor activity (4,17,22-24). However, 
much discrepancy exists between studies, as discussed previously by Adams (2). Sensitive 
and reliable methods to assess spontaneous motor behavior following prenatal administration 
of retinoids have not been previously utilized. The results of the present study indicate no 
significant changes in the spontaneous motor behavior of animals dosed with A1 (3.5-35 
|imol/kg BW) or RA (1-11 |imol/kg BW). Findings from other behavioral studies using 
similar dosing protocols to the present study (dosing on day 8.5 of gestation) have been 
inconsistent (1,3,4,13,17,22,23). Approximately one half of all data acquired fi-om dose 
ranges of A1 (26-105 (imol/kg BW) have indicated alteration of behavior (3,4,13,22,23), 
while one half have indicated no behavioral modification (3,22,23). The lowest dose of A1 
shown to aher behavior in rats postnatally is 11 |amol/kg BW, which altered shock avoidance 
behavior (22). Open field tests, designed to measure changes in motor activity, did not 
indicate behavior modification from doses of A1 ranging from 11-42 |jmol/kg BW (22). 
Likewise, in the present study we see no behavioral effect at these dose levels of A1. 
Similarly, RA has been shown to alter reflex development and preweaning activity behaviors 
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at 17 nmol/kg when dosed on day 8-10 of gestation (17). To our knowledge, motor activity 
has not been measured for animals dosed with RA on day 8.5 of gestation. Administration of 
RA at day 8.S of gestation in the present study did not alter behavior. 
In contrast to A1 and RA, A2 strongly affected behavior of six-week old rats, just as 
A2 was more potent at reducing live birth rate than either A1 or RA. Profound behavioral 
changes were observed in six week old females dosed prenatally with 1 |amol/kg BW and 
males dosed prenatally with 3.5 ^imol/kg BW. Curiously, higher doses of A2 for both males 
and females (11 fimol/kg BW for males and 3.5-11 ^mol/kg BW for females), and a lower 
dose of A2 for males (1 nmol/kg BW) did not Induce behavioral abnormalities. Females are 
more sensitive than males to A2 induced behavioral changes, with behavior modification 
occurring at the lowest dose of 1 ^mol/kg BW for females. The frequency of occurrence, 
total time, time distribution and time sequence of behavioral acts for both the molecular and 
the molar taxonomies were all altered by treatment for both of these groups (Table 6). Time 
sequence is profoundly altered in the female 1 ^mol/kg BW treatment group, and less so 
(although significantly different from control) in the male group dosed with 3.5 ^imol/kg BW. 
Nineteen of the total 39 behavioral changes (49%) in the female group are disruptions of the 
time sequence of behaviors. Approximately 38% of the behavioral changes identified for the 
male group are disruptions of the time sequence of behaviors. Sequence of behavior is highly 
structured and difficult to disrupt (18), and cannot currently be measured with any other 
automated methodology. While other behavioral measures such as frequency or time 
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distribution of behaviors may have indicated significant changes if analyzed alone, the time 
sequence measures identified the greatest area of change. 
Table 7 identifies specific behavioral changes between female control animals and 
those exposed to 1 |amol/kg BW A2. The frequency of occurrence for the molecular acts 
grooming, head turn, and smelling were significantly diflferent from control animals (p < 0.05, 
0.05, and 0.01, respectively). The total time of individual molecular acts was significantly 
changed for the behaviors sit, blank, grooming, and head turn (p £ 0.05 for all). Combined 
acts significantly altered due to exposure of female offspring to 1 pimol/kg BW A2 prenatally 
included changes in the frequency of the acts groom, explore, and explore/attention (p<0.05 
for all). Thus, the behavior of the female group dosed with 1 nmol/kg BW A2 appears to be 
disrupted in a variety of ways. In general, activities requiring whole body displacement were 
reduced, while activities not related to whole body displacement and time needed for sensory 
perception and attention tended to increase. 
Table 8 identifies specific behavioral changes between male control animals and those 
exposed to 3.5 nmol/kg BW A2. The frequency of occurrence for the molecular acts walk 
and smell were significantly different from control animals (p < 0.05 for both). Frequency of 
the explore combined acts was also significantly different from control (p < 0.05). Total time 
spent on behavior was significantly changed for the molecular acts stand and walk (p < 0.01 
for both), and combined acts explore and attention (p < 0.05 for both). An increase in overall 
motor activity is seen for the treated male animals, with a slight decrease in stationaiy acts. 
55 
Thus, unlike the female animals, males seem to be affected in a manner that increases overall 
activity. 
The difference between the effect of A2 on the two sexes then, is an overall affect to 
decrease activity in females and to increase activity in males. While no other behavioral data 
exists for effects of A2, sex differences in growth response and liver storage of A2 have been 
reported (21). Female vitamin A deficient rats, supplemented daily with 0.11 (xmol of A2 for 
6 weeks, gained only 54% of the weight gained by male rats under the same conditions. 
When all animals received a normal intake of A1 but then were supplemented with A2 for a 
two week period (21), female rats stored only 55% as much A2 in the liver as male rats. 
Thus, males and females seem to metabolize A2 quite differently. 
Dose Response 
The lack of a true dose response in offspring given A2 during gestation has been 
observed previously (unpublished findings, Duitsman and Olson). Embryolethality for 
offspring of pregnant animals dosed with A2 at levels 3.5-352 jxmol/kg BW on day 8.5 of 
gestation peaked at the mid-range dose of 35 |imol/kg BW (unpublished findings, Duitsman 
and Olson). At higher doses of A2 (113 and 352 |imol/kg BW), embryolethality was less than 
(50% and 10%, respectively) that observed at the mid-range dose. Unlike A2, RA dosed 
under the same conditions induced embryolethality in a linear dose response manner. Tissue 
concentrations of RA on day 19.5 of gestation following a dose of A2 on day 8.5 of gestation 
did not accumulate in a dose-dependent manner (Duitsman and Olson, unpublished findings). 
Accumulation of RA in the livers of A2 dosed pregnant animals, and their offspring, tended 
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to increase at a mid-range dose of A2. Animals dosed with A1 and RA under the same 
conditions did not contain RA in liver tissue at 19.5 days. Thus, it appears that metabolism 
and transport of A2 during gestation markedly differ from that of A1 and RA. Also, it seems 
evident that accumulation of RA in the tissues of these animals is unique to A2 dosed animals. 
While behavioral effects identified in the present study occurred at much lower doses 
than gross effects previously observed as a result of A2 treatment, patterns of the dose 
response curve were similar. Behavioral changes due to retinoid administration have been 
shown to occur at levels ten times less than those concentrations inducing gross terata. In the 
present study, behavioral changes elicited by A2 were remarkable for males at doses 3 times 
less than doses of A2 which have elicited significant embryolethality. Behavioral changes for 
female rats in the present study occurred at a dose level of A2 that was 10 times less than 
concentrations which have produced embryolethality. Both sexes, therefore, are much more 
sensitive to A2 induced behavioral changes than to gross terata in response to a prenatal dose 
ofA2. 
The lack of dose response and increased sensitivity to behavioral changes in the A2 
groups was unique among the retinoids tested. However, the large numbers of control 
animals used to ensure reliable statistical manipulation of the data, and the sensitivity, 
specificity, and reliability of the methodology used lends credence to our findings. Behavioral 
data collected from control animals used to test all three retinoids showed no differences in 
behavior between control animals (n = 240). Therefore, significant differences in behaviors 
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for females rats dosed with 0.001 mmol/kg BW A2 and males dosed with 0.004 mmol/kg BW 
A2, when compared with control animals, appear to exist. 
LITERATURE CITED 
1. Adams, J. Ultrasonic vocalization as diagnostic tools in studies of developmental toxicity; 
An investigation of the effects of hypervitaminosis A. Neurotoxicol. Teratol. 4:299-304; 
1982. 
2. Adams, J. Structure-activity and dose-response relationships in the neural and behavioral 
teratogenesis of retinoids. Neurotoxicol. Teratol. 15:193-202; 1993. 
3. Butcher, R. E.; Brunner, R. L.; Roth, T.; Kimmel, C. A. A learning impairment associated 
with maternal hypervitaminosis-A in rats. Life Science 2:141-145; 1972. 
4. Coyle, I. R.; Singer, G. The interaction of post-weaning housing conditions and prenatal 
drug effects on behavior. Psychopharmacologia 41:237-244; 1975. 
5. Diggle, P. J. Statistical analysis of spatial point patterns. New York: Academic Press; 
1983. 
6. Gunning, D. B.; Baura, A. B.; Olson, J. A. Comparative teratogenicity and metabolism of 
2\\-trans retinoic acid, ?SX-trcms retinoyl P-glucose, and z\\-trcms retinoyl f3-glucuronide in 
pregnant Sprague-Dawley rats. Teratol. 47:29-36; 1993. 
7. Hopper, D. L.; Keman, W. J.; Wright, J. R. Computer pattern recognition: An 
automated method for evaluating motor activity and testing for neurotoxicity. 
Neurotoxicol. Teratol. 12:419-428; 1990. 
8. Keman, W. J.; Mullenix, P. J.; Hopper, D. L. Pattem recognition of rat behavior. 
Pharmacol. Biochem. Behav. 27:559-564; 1987. 
9. Keman, W. J.; Mullenix, P. J.; Kent, R.; Hopper, D. L.; Cressie, N. A. C. Analysis of the 
time distribution and time sequence of behavioral acts. Intern. J. Neuroscience 43:35-41; 
1988. 
10. Keman, W. J.; Hopper, D. L.; Bowes, M. P. Computer pattem recognition: Spontaneous 
motor activity studies of rats following acute exposure to triethyhin. J. Am. Coll. Toxicol. 
10:705-718; 1991. 
58 
11. Keman, W. J.; Meeker, W. Q. A statistical test to assess changes in spontaneous behavior 
of rats observed with a computer pattern recognition system. J. Biopharmaceutical 
Statistics. 2:115-135; 1992. 
12. Kutz, S. A.; Troise, N. J.; Cimprich, R. E.; Yearsley, S. M.; Rugen, P. J. Vitamin A 
acetate: a behavioral teratology study in rats. Drug Chem. Toxicol. 12:259-275; 1989. 
13. Mooney, M. P.; Hoyenga, K. T.; Hoyenga, K. B.; Morton, J. R. C. Prenatal 
hypervitaminosis A and postnatal behavioral development in the rat. Neurobehav. 
Toxicol. Teratol. 3:1-4; 1981. 
14. Mullenix, P. J.; Keman, W. J. Extension of the analysis of the time structure of behavioral 
acts. Intem. J. Neurosci. 44:251-262; 1989. 
15. MuHenix, P. J.; Keman, W. J.; Tassinari, M. S.; Schunior, A. Generation of dose-
response data using activity measures. J. Am. Coll. Toxicol. 8:185-197; 1989. 
16. Nau, H.; Chahoud, I.; Dencker, L.; Lammer, E. J.; Scott, W. J. Teratogenicity of vitamin 
A and retinoids. In: Blomhofif, R., ed. Vitamin A in Health and Disease. New York: 
Marcel Dekker, Inc.; 1994:615-663. 
17. Nolen, G. A. The effects of prenatal retinoic acid on the viability and behavior of the 
offspring. Neurotoxicol. Teratol. 8:643-654; 1986. 
18. Norton, S. The study of sequences of motor behavior. In: Iverson, L. L.; Iverson, S. D.; 
Snyder, S. H., eds. Handbook of psychopharmacology, vol. 7. London: Plenum Press; 
1977:83-105. 
19. Ripley, B. D. Spatial statistics. New York: John Wiley and Sons; 1981. 
20. Sackett, G. P.; Ruppenthal, G. C.; Gluck, J. An overview of methodological and 
statistical problems in observational research. In: Sackett, G. P., ed. Observing behavior, 
vol. 2. Data collection and analysis methods. Baltimore: University Park Press; 1978:1-
14. 
21. Shantz, E. M.; Embree, N. D.; Hodge, H. C.; Wills, J .  H. Jr. The replacement of vitamin 
A1 by vitamin A2 in the retina of the rat. J. Biol. Chem. 163:455-64; 1946. 
22. Vorhees, C. V. Some behavioral effects of maternal hyper-vitaminosis A in rats. Teratol. 
10:269-274; 1974. 
59 
23. Vorhees, C. V.; Brunner, R. L.; McDaniel, C. R.; Butcher, R. E. The relationship of 
gestational age to vitamin A induced postnatal dysfunction. Teratol. 17:271-276; 1978. 
24. Vorhees, C. V.; Brunner, R. L.; Butcher, R. E. Psychotropic drugs as behavioral 
teratogens. Science 205; 1220-1225; 1979. 
60 
Table 1. Behavioral acts in the molecular and molar act taxonomies. 
Molecular Molar 
Major Molar Molecular Modifying Molecular Molar 
Body Act Modifying Act Joint Joint 
Position Label Act Label Acts Acts 
Stand A* Blank 
Sit G Groom 
Rear E Head turn 
Walk E Look 
Lying Down G Snifr 
Unclassified Smell 
Turn 
Washing Face 
A Stand-Blank A-A 
G Stand-Groom A-G 
A Stand-Head turn A-A 
A Stand-Look A-A 
E Stand-Sniff A-E 
A Stand-Smell A-A 
E Stand-Turn A-E 
G Sit-Blank G-A 
Sit-Groom G-G 
Sit-Head turn G-A 
Sit-Look G-A 
Sit-SnifF G-E 
Sit-Smell G-A 
Sit-Tum G-E 
Sit-Wash face G-G 
Rear-Blank E-A 
Rear-Sniff E-E 
Rear-Smell E-A 
Rear-Tum E-E 
Walk-Blank E-A 
Walk-Head turn E-A 
Walk-Look E-A 
Walk-Sniff E-E 
Walk-SmeU E-A 
Walk-Turn E-E 
Lying down- G-A 
Blank 
Lying down- G-A 
Head turn 
Unclassified 
* A = attention, E = exploratory, G = grooming. 
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Table 2. Definitions of behavioral acts in the RAPID behavioral act taxonomy. 
Definition 
Major body positions 
Stand 
Sit 
Rear 
Walk 
Lying down 
Unclassified 
Modifiers* 
Blank 
Grooming 
Head turning 
Looking 
SnifiBng 
Smelling 
Turning 
Washing face 
Rat on four feet, not moving compared to previous frame 
Forequarters raised, forepart and hindpart of body almost 
at right angle, hindpart of body on floor 
Body inclined vertically, forequarters raised 
Rat on four feet and moving compared to previous fi-ame 
Body ventral surface on floor, not moving 
(5 fi-ames minimum required) 
No major body position can be identified 
No modifier can be identified 
Mouth or paws on body 
Head moved horizontally more than 15° compared to 
previous firame 
Head up, not against an object, not moving compared to 
previous frame 
Nose in one of the holes in the observation cage 
Nose against object, floor or walls and not moving 
compared to previous frame 
Head and body moved horizontally more than 20° 
compared to previous frame 
Forepaws on head 
*Note: In all act modifiers movement takes precedence over other modifiers. 
62 
Table 3. Live birth rates (%) and mean weight gain/loss of offspring from rats dosed 
with retinoids on day 8.S of gestation, when compared to control animals. 
Treatment Dose Sex of animal %Live Mean weight (g) 
(nmol/kg BW) births gain (+) 
or loss (-) 
A2 11 Male 85% +2.77 
3.5 Male 96% -6.92 
1 Male 100% -1.07 
11 Female 89% +0.38 
3.5 Female 89% +2.31 
1 Female 94% +0.10 
A1 35 Male 100% -1.50 
11 Male 100% +12.24** 
3.5 Male 100% +8.43 
RA 11 Male 100% -4.34 
3.5 Male 100% -5.41 
1 Male 100% -4.58 
**p<0.01 
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Table 4. Value of the RS statistic for the comparison of each of 12 treatment 
groups with their controls (n=20 for each group). 
Treatment Dose Sex of RS 
(fimol/kg BW) animal 
A2 11 Male 0.052 
3.5 Male 0.220*** 
1 Male 0.015 
11 Female 0.090 
3.5 Female 0.062 
1 Female 0.825*** 
A1 35 Male 0.030 
11 Male 0.044 
3.5 Male 0.081 
RA 11 Male 0.066 
3.5 Male 0.092 
1 Male 0.032 
***p^0.001 
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Table 5. Summaiy of behavioral act modification in six-week old rats 
following prenatal exposure to A1 and RA. 
Behavioral acts^ A1 (nmol/kg BW) RA (^mol/kg BW) 
3.5 11 35 1 3.5 11 
REGULAR 
NOCC 1 0 0 0 0 1 
Time 1 1 0 1 0 2 
MBP-TD 0 1 1 0 1 0 
MBP-TS 1 0 0 0 1 0 
MOD-TD 0 0 0 0 0 1 
MOD - TS 1 0 1 0 1 0 
COMBINED 
NOCC 0 0 0 0 0 0 
Time 1 1 0 0 0 1 
TD 0 0 0 0 1 0 
TS 1 0 0 1 2 0 
TOTAL 6 3 2 2 6 5 
CHANGES 
RS 0.08 0.04 0.02 0.03 0.09 0.06 
MOVE 1.02 1.21 0.1 0.84 0.93 0.19 
'NOCC=number of occurrences (fi-equency), MBP=major body position, 
TD=time distribution, TS=time sequence, MOD=modifier acts. 
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Table 6. Summary of behavioral act modification in six-week old rats following 
prenatal exposure to A2. 
Behavioral acts' A2 Dose 
(1 ^mol/kgBW) (3.5 ^imol/kgBW) (11 (imol/kgBW) 
Male Female Male Female Male Female 
REGULAR 
NOCC 0 3 2 0 1 1 
Time 0 4 2 0 0 1 
MBP-TD 0 3 1 0 1 0 
MBP-TS 0 6 1 1 0 0 
MOD-TD 0 0 1 0 0 1 
MOD - TS 1 3 3 0 1 2 
COMBINED 
NOCC 0 3 1 0 0 0 
Time 0 3 2 0 0 0 
TD 0 4 1 0 0 1 
TS 0 10 2 2 0 0 
TOTAL 1 39 16 3 3 6 
CHANGES 
RS 0.01 0.13*** 0.22*** 0.06 0.05 0.09 
MOVE 0.4 1.52 2.37* 0.72 2 0.36 
'NOCC=number of occurrences, MBP=major body position, TD=time distribution, 
TS=time sequence, MOD=modifier acts. 
*p<0.05 
***p<0.001 
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Table 7. Frequency and total time of behavioral acts for six-week old female rats 
exposed to the vehicle alone (control) or to I nmol/kg BW A2 prenatally. 
Number of occurrences Time ± SEM 
+ SEM 
Act Control Exposed Control Exposed 
Stand 131.3 ±3.9 141.4 ±3.3 506.4 ±11.9 511.6±11.1 
Sit 21.6 ±2.1 22.3 ± 1.6 98.3 ± 17.6 51.6 ±5.2* 
Rear 47.7 ±3.2 56.7 ±3.4 143.0 ± 10.5 172.1 ± 11.7 
Walk 92.7 ±3.6 101.4 ±2.7 147.8 ±6.1 163.6 ±5.8 
Lying 0.4 ± 0.3 0.2 ± 0.4 4.5 ±3.4 1.1 ±0.5 
Blank 124.7 ± 3.0 121.3 ±2.3 327.6 ± 12.0 292.5 ± 8.7* 
Grooming 11.2 ±2.3 5.2 ±0.7* 20.0 ±4.8 8.1 ± 1.5* 
Head turn 43.2 ± 1.7 50.7 ±2.7* 48.8 ±2.1 59.2 ±3.2* 
Looking 2.9 ± 0.4 4.1 ±0.6 3.0 ±0.4 4.2 ±0.6 
Sniffing 9.6 ±1.9 13.3 ±2.8 14.6 ±3.0 20.5 ±4.7 
Smelling 108.4 ±4.0 122.2 ±3.0** 266.1 ±13.3 296.6 ± 8.6 
Turning 120.6 ±2.7 121.5 ±2.1 217.3 ±5.1 218.2 ±5.3 
Wash face 1.6 ±0.5 0.6 ±0.2 2.5 ±1.0 0.7 ±0.2 
Combined Actst 
Groom 
Explore 
Groom/Explore 
Attention 
Groom/Attention 
Explore/Attention 
*p<0.05 
**p<0.01 
•Combined acts (A,E,G) are composed of several molar acts. Groom is not the 
same as grooming, which is a molecular modifying act. 
11.4 ±2.4 
73.6 ±3.3 
24.0 ±3.3 
143.8 ±4.0 
22.5 ±3.7 
146.2 ±4.3 
4.9 ±0,7* 
84.3 ±3.2* 
17.0 ±1.8 
151.9 ±2.7 
15.9 ±1.7 
157.5 ±2.8* 
19.9 ±4.8 
97.1 ±4.4 
37.5 ±5.2 
406.4 ± 9.7 
48.1 ±13.1 
291.1 ±11.0 
6.8 ±1.3* 
110.8 ±5.3 
23.8 ±2.6* 
405.5 ±9.9 
24.0 ±3.1 
328.9 ±9.1* 
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Table 8. Frequency and total time of behavioral acts for sbc-week old male rats 
exposed to the vehicle alone (control) or to 3.5 |amol/kg BW A2 prenataliy. 
Number of occurrences Time ± SEM 
±SEM 
Act Control Exposed Control Exposed 
Stand 130.1 ±3.6 141.2 ±4.7 558.9 ±8.5 527.1 ±7.8** 
Sit 29.8 ±2.2 26.8 ±1.6 79.9 ± 8.3 73.8 ±7.7 
Rear 41.0 ±2.8 41.3 ±2.4 102.7 ±8.0 109.4 ± 6.5 
Walk 97.6 ±3.5 110.1 ±4.4* 157.8 ±7.3 189.4 ±8.3** 
Lying 0.1 ±0.1 0.1 ±0.1 0.6 ± 0.6 0.3 ± 0.3 
Blank 120.5 ±3.7 114.9 ±2.8 283.6 ±9.8 267.5 ± 9.4 
Grooming 7.6 ± 1.3 5.3 ±0.7 10.7 ±2.1 7.6 ± 1.3 
Head turn 55.3 ±2.7 54.8 ±1.8 63.4 ±3.2 63.0 ±2.2 
Looking 3.6 ±0.4 4.5 ±0.6 3.6 ±0.5 4.9 ±0.7 
SnifRng 11.8 ±2.1 11.2±2.1 20.0 ±4.2 19.6 ±4.0 
Smelling 113.4 ±3.4 124.3 ±3.4* 292.4 ± 11.1 295.3 ± 8.7 
Turning 125.7 ±2.8 130.0 ±2.5 225.3 ± 7.6 241.3 ±6.9 
Wash face 0.8 ±0.3 0.6 ±0.2 1.1 ±0.4 0.7 ± 0.2 
Combined Acts* 
Groom 
Explore 
Groom/Explore 
Attention 
Groom/Attention 
Explore/Attention 
*p^0.05 
**p<0.01 
^Combined acts (A,E,G) are composed of several molar acts. Groom is not the 
same as grooming, which is a molecular modifying act. 
7.3 ± 1.2 
77.7 ±4.1 
25.3 ±2.2 
144.9 ± 2.5 
21.6 ±2.3 
145.8 ±3.3 
5.1 ±0.6 
90.4 ±3.8* 
21.5 ±1.7 
147.0 ±4.1 
21.9 ±1.9 
152.3 ±3.7 
9.7 ±1.7 
101.5 ±5.9 
35.6 ±3.3 
448.7 ± 10.0 
37.3 ±4.7 
267.2 ± 8.0 
6.9 ± 0.9 
123.2 ± 6.4* 
31.9±3.3 
419.9 ±9.3* 
36.7 ±4.9 
281.4 ±7.8 
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ABSTRACT 
The vitamin A status of low-income women (n = 57) during the third trimester of 
pregnancy was assessed by use of the modified relative dose response (MRDR) test. Non-
Hispanic White (45), Hispanic (6), Afro-American (5), and Asian (1) women were recruited 
from public health programs in central Iowa. Serum retinol, P-carotene, a-carotene, 
lycopene, a-tocopherol, and cholesterol concentrations were also measured. Twenty six 
percent of the study population were found to be in a marginal vitamin A status with MRDR 
values >0.03, whereas 9% had values SO.06. The Hispanic and Afro-American groups 
seemed to be most at risk, with 50% and 40% (respectively) of the MRDR values >0.03 and 
33% and 20% (respectively) >0.06. Carotenoid values were similar to those found in women 
in other like studies, except for the Afro-American group, which had mean values less than 
half those of the other groups. a-Tocopherol concentrations and a-tocopherol/cholesterol 
ratios of all ethnic groups fell in the normal range. The somewhat elevated cholesterol levels 
found in all groups can largely be attributed to pregnancy. Clearly, this study identifies a 
portion of the U.S. population at high risk of vitamin A inadequacy. 
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INTRODUCTION 
An adequate supply of vitamin A from maternal tissue is critical for normal growth and 
development of the fetus. A marginal or deficient maternal vitamin A status is associated with 
babies of low birthweight and with a greater incidence of morbidity and mortality (1-3). 
Because maternal tissue is progressively depleted of vitamin A so as to supply fetal demands 
(4), pregnant women who initially possess marginal vitamin A reserves are at an increased risk 
of vitamin A inadequacy as pregnancy progresses. This situation may particularly develop in 
low-income households without sufficient funds to purchase fresh fhiits and vegetables or to 
provide proper storage for dairy products. Much attention has been given to this problem in 
third-world countries, but only to a minor extent in the United States. 
Marginal vitamin A status, which is defined as a condition of vitamin A inadequacy 
without the presence of clinical signs of deficiency, is best assessed biochemically by use of 
dose-response tests. The modified relative dose-response (MRDR) test, which was developed 
in this laboratory to assess marginal vitamin A status (S-8), is similar in principle to the 
relative dose-response (RDR) test (9). A dose of 3,4-didehydroretinyl acetate (DRA) 
administered orally elicits the release of accumulated apo-retinol-binding protein (apo-RBP) 
from the liver as holo-RBP (10). Five hours after dosage, both 3,4-didehydroretinol (DR) and 
retinol (R), which can readily be separated by high-pressure liquid chromatography (HPLC), 
are found in the plasma. Thus, the MRDR test requires only one blood sample, whereas the 
RDR test requires two. The ratio of DR to R at S h, above a selected cutoff value, is inversely 
related to vitamin A status. 
In this study, we have investigated the response of low-income pregnant women in the 
third trimester of pregnancy to an oral dose of 8.8 lamol (2.5 mg) DRA. We have also 
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measured the concentrations of retinol, three carotenoids, a-tocopherol, and cholesterol in the 
serum of these subjects. 
METHODS AND MATERIALS 
Subjects 
Low-income pregnant women were recruited from state and federally funded health­
care programs in central Iowa. Field sites included the Broadlawns Hospital Family Clinic, 
Homes of Oakridge, the Women, Infants and Children (WIC) Clinic in Des Moines, and also 
the WIC clinics in Ames and Marshalltown, Iowa. All women involved in these clinics were 
required to be of low-income status, which is defined as a monthly income of $1,135 or less 
for a single mother and of $2,282 or less for a four-member family. Criteria for inclusion in 
the study included low-income status, general good health, adherence to a suggested diet 
preceding the test, and a willingness to have the test performed during the seventh month of 
pregnancy. Women who were not of low-income status, who were in poor health, or who 
were unwilling to undergo diet constraints or blood drawings were excluded. Consent forms 
were signed at the time of recruitment, and appointments were made for the subjects to return 
for the test during their seventh month of pregnancy. 
Of approximately 170 pregnant women approached about the study, 92 expressed 
interest in participating. Thirty-five women failed to meet all inclusion criteria and were 
excluded. Of the 57 enrolled subjects, 45 were non-Hispanic White, 6 were Hispanic, 5 were 
Afro-American, and 1 was Asian. All were studied during the seventh month of pregnancy. 
Subjects ranged in age from 15 to 37 years. All subjects had access to prenatal multivitamins, 
which contained 4,000-10,000 lU of preformed vitamin A, 11-45 lU of vitamin E (as 
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dl-a-tocopheryl acetate), and 50-240 mg of vitamin C. None of the vitamin preparations 
contained provitamin A compounds, such as P-carotene. The subjects were asked not to 
ingest vitamin supplements on the day before or on the day of the test. A list containing 
approximately ten foods essentially free of vitamin A and carotenoids was provided to each 
participant. Subjects were also asked to avoid certain foods for the day before the test, such 
as milk and milk products, eggs, fortified cereals, and meats to avoid any interference with the 
test from a high intake of preformed vitamin A. On the day of testing, a 24-h recall for dietary 
intake was taken. Four subjects who ingested food products containing large amounts of 
preformed vitamin A that might have interfered with the test were excluded. 
Methods 
3,4-Didehydroretinyl acetate (DRA) was synthesized from retinoic acid (5,11) and 
then purified twice on a colunm of 8% water-deactivated alumina. Its purity, as judged by 
absorption at 350 nm, and determined HPLC, was 98.6%. No retinyl acetate (RAC), which 
separates well from DRA on HPLC, was detected (detection limit = 0.5 ng; or <0.01%). An 
oral dose of 8.8 |imol (2.S mg) DRA dissolved in com oil was pipetted directly into the mouth 
of each subject by using a Gilson positive-displacement pipette (Rainin Instruments, Wobum, 
MA). The dose was followed by an ice cream snack, essentially free of vitamin A, which 
contained approximately 10 g of fat to aid absorption of the retinoid. Five hours after the 
DRA was administered, venous blood samples were obtained by a licensed phlebotomist at the 
field site. Blood samples were collected into serum separation tubes, put in a cooler, and 
taken promptly back to the laboratory. Serum was collected after centriftigation at 5,500 rpm 
for 20 min, sealed under argon, and stored at -20°C for approximately four months. Thus, the 
concentrations of carotenoids, retiniol, and a-tocopherol may have been somewhat lower 
upon analysis. However, DR/R should not be affected by storage at these conditions. 
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The DR/R ratio was analyzed by standard procedures developed in our laboratory (5). 
In brief, 500 nl of serum from each volunteer was mixed with an equal volume of ethanol 
containing SO (0.14 |ag) RAC, which was used as an internal standard. Serum was 
extracted with 500 ^1 hexane (3 times). Hexane fractions were pooled and evaporated to 
dryness under a slow stream of argon gas. The residue was redissolved in 50 |il of 
methanol:dichloromethane (4:1 v/v) for analysis by HPLC. Each sample was applied to a 
5 lim Ci8 Waters Resolve reversed-phase column by use of a WISP autoinjector (Waters, 
Milford, MA). A Waters 996 photo-diode array (PDA) detector monitored absorbance at 
350 nm for DR and at 325 nm forR and RAC, while a Waters 510 pump was set at a flow 
rate of 1.0 ml/min. An isocratic solvent system (methanol:water, 90:10 v/v) was run for 13 
min to separate the three analytes. Retention times for DR, R, and RAC were 7, 8, and 13 
min, respectively. The Millermium 2010 software version 1.2, which was developed by 
Waters for use with their 996 PDA detector, performed data acquisition, processing, and 
management of chromatographic information. All data were acquired and stored in three-
dimensional mode, which allowed detailed examination of selected spectra, integration of peak 
areas, and assessment of the purity of compounds. All analyzed data were printed by use of a 
Hewlett Packard Laser Jet 11 printer. The molar DR to R ratio was then calculated as 
previously described (5). 
The analysis of carotenoids and tocopherols were conducted by standard procedures 
described in our laboratory (12). In brief, 100 |al of serum was mixed with 100 |al ethanol 
containing 50 nl (3.14 |ag) all-rac-a-tocopheryl acetate, which was used as an internal 
standard. Serum was extracted by using 200 |.tl of hexane three times. Extracts were pooled 
and evaporated to dryness under a slow stream of argon gas. Residues were redissolved in 
100 ^1 of methanol;methylene dichloride (75:25, v/v), and an aliquot (40 ^1) was injected by 
use of a Waters WISP autoinjector onto a Waters Resolve 5 |im Cig 30-cm reversed-phase 
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HPLC column. The isocratic solvent system was composed of methanol, acetonitrile, 
ethylene dichloride, and octanol (50:50:15:0.12 by volumes) and contained 0.05% ammonium 
acetate. P-Carotene (t^ =10.9 min), a-carotene (tf =10.2 min), and lycopene (tr = 8.2 min) 
were monitored at 450 nm, a-tocopherol (tj- = 6.4 min) at 292 nm, and a-tocopheryl acetate 
(tf = 7.0 min) at 285 nm. The HPLC setup was identical to that used for DR/R analysis, as 
already described. 
Cholesterol analysis was performed using a Kodak Ektachem DT60n analyzer 
(Eastman Kodak Co., Rochester, NY). A 10 |il drop of serum from each subject was 
deposited on a Kodak Ektachem DT slide. In the analysis, cholesteryl esters are hydrolyzed 
to cholesterol, which is then oxidized by cholesterol oxidase to generate hydrogen peroxide. 
The hydrogen peroxide oxidizes a leuco dye in a peroxidase-catalyzed reaction to produce a 
colored compound. Colorimetric measurement by reflectance spectrophotometry provides the 
basis for the final cholesterol concentration value. Serum a-tocopherol concentrations are 
reported as i^mol/L and as {^mol/mmol cholesterol. All samples were analyzed in duplicate. 
Statistics 
Regression, univariate, and Pearson correlation coefficients were determined by use of 
the Statistical Analysis System, version 6.0, Cary, NC. Chi-square analysis of a contingency 
table was conducted by conventional procedures (13). 
RESULTS 
Characteristics of the whole study population 
The age, MRDR ratios, and values for selected serum components are given in Table 
1. The frequency distributions of serum concentrations of retinol, a-tocopherol, and 
cholesterol and of a-tocopherol/cholesterol ratios were approximately normal, whereas those 
TABLE 1 
Mean, Median, and Ranges of DR/R Ratios and of Seaim Components in the Study Subjects 
Variable n Mean ± SD Median Range 
DR/R ratio (|amoI/|imol) 57 0.026 ±0.017 0.021 0.006 - 0.082 
Retinol (nmol/L) 57 1.57 ±0.51 1.55 0.82 - 3.12 
P-Carotene (nmol/L) 56 0.16 ±0.18 0.12 0.00 - 0.99 
a-Carotene (jamoI/L) 56 0.05 ±0.04 0.056 0.00 - 0.16 
Lycopene (nmol/L) 56 0.47 ± 0.40 0.36 0.04 - 2.14 
a-Tocopherol (jamol/L) 56 32.6 ±7.60 43.1 19.1 -57.4 
Cholesterol (mmol/L) 56 5.7 ±1.39 5.5 3.23 - 9.05 
a-Tocopherol/ChoIesteroI Ratio 
(nmol/mmol cholesterol) 
56 6.0 ± 1.86 5.6 2.9 - 11.5 
Age (years) 42 22.5 ± 5.0 21.5 15 -37 
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of MRDR ratios and of the three carotenoid concentrations were skewed towards larger 
values (Fig. 1,2). By using suggested serum cutoff values of inadequacy for several nutrients 
(6,14, IS) and of cardiovascular risk for serum cholesterol (16), the study population showed 
a state of inadequacy relative to vitamin A and of risk of atherosclerosis relative to cholesterol 
(Table 2). 
DR/R 
0.09 
3,4 - Didehydroretinol to Retinol Ratio in the Serum 
FIG 1. Frequency distribution of MRDR values for all pregnant women in the study. 
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FIG 2. Frequency distribution of carotenoids for all pregnant women in the study. 
TABLE 2 
Percentages of Study Subjects at Nutritional Risk 
Item Cutoff value of inadequacy or risk Percent at risk 
MRDR ratio >0.03 26% 
>0.06 9% 
Retinol <1.05 |imol/L 18% 
<0.70 |AmoI/L 0% 
a-Tocopherol <16 nmol/L 0% 
a-T ocopherol/cholesterol <2.2 nmole/mmole 0% 
Cholesterol >5.7 mmol/L 48% 
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Effects of ethnicity 
Mean values for the MRDR ratios and for serum components as well as the 
percentages of various ethnic groups at risk are given in Table 3. Although vitamin A 
inadequacy was noted in all ethnic groups except for the single Asian studied, pregnant 
Hispanic and Afro-American women seemed to be more affected than the non-Hispanic White 
group. Probably because the former two groups were small, however, the differences by Chi-
square analysis were not significant (p > 0,10) when a cutoff value of 0.03 was used and only 
approached significance (p < 0.10) when a cutoff value of 0.06 was employed. 
Carotenoid patterns differed among the four groups. The sum of the three measured 
carotenoids in the Afro-American group was less than half that in the other groups. The 
Hispanic and Asian groups showed relatively larger amounts of a- plus P-carotene (50-62%) 
and smaller amounts of lycopene (38-50%), whereas the Afi-o-American and non-Hispanic 
White groups showed just the opposite, low a- and P-carotene (25-28%) and high lycopene 
(72-75%). 
Correlations between measured parameters 
The Pearson correlation coeflBcients and probability (P) values (two-tailed) of selected 
compared values are given in Table 4. MRDR values were inversely and significantly related 
to serum retinol concentrations, a correlation that is largely driven by MRDR ratios >0.03 
(Fig. 3). In this regard, MRDR values <0.03 were not correlated (r = -0.07, p = 0.65) with 
serum retinol concentrations of subjects in this subgroup. Serum carotenoid concentrations 
were correlated with each other and, except for P-carotene, also with serum a-tocopherol 
levels. MRDR ratios did not correlate with any other measured parameter (Table 4), nor were 
any other two parameters correlated in any significant way. 
TABLE 3 
MRDR Ratios, Mean Values of Serum Components, and Percentages at Risk 
for Ethnic Groups among the Pregnant Women in the Study 
Parameter Non-Hispanic White Hispanic Afro-American Asian 
(n = 45) (n = 6) (n = 5) (n = 1) 
MRDR ratio 0.023 ± 0.023 0.040 ± 0.023 0.038 ± 0.030 0.013 
% >0.03 22% 50% 40% 0 
% >0.06 4% 33% 20% 0 
Retinol (/imoi/L) 1.6 ± 0.5 1.5 ± 0.6 1.2 + 0.3 2.0 
% <1.05 fimol/L 13% 17% 60% 0% 
a-Tocopherol/cholesterol 6.2 ± 1.9 6.2 ± 1.8 4.2 ± 1.0 5.9 
(/imol/mmol) 
% < 2.2/xmol/mmo! 0% 0% 0% 0% 
Cholesterol (mmol/L) 5.7 ± 1.4 5.3 ± 0.9 6.4 ± 1.3 5.8 
% >5.7 mmol/L 49% 40% 60% 
j8-Carotene (nmol/L) 152 ± 165 (125)* 301 ± 285 (208)* 60 ± 27 (57)* 317 
a-Carotene (nmol/L) 50 ± 35 (71)* 86 ± 8 (85)* 23 ± 34 (0)* 160 
Lycopene (nmol/L) 513 ± 426 (384)* 391 ± 238 (470)* 250 ± 145 (286)* 289 
•Median values are given in parentheses. 
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TABLE 4 
Pearson Correlation Coefficients of Compared 
Parameters in the Whole Study Group of Pregnant Women 
Values compared r £ 
MRDR vs. retinol -0.48 0.0002 
P-Carotene vs. a-carotene 0.50 0.0001 
P-Carotene vs. lycopene 0.31 0.02 
a-Carotene vs. lycopene 0.49 0.0001 
a-Tocopherol vs. a-carotene 0.35 0.007 
a-Tocopherol vs. lycopene 0.42 0.001 
a-Tocopherol vs P-carotene 0.05 0.74 
MRDR vs p-carotene -0.02 0.87 
MRDR vs a-carotene -0.12 0.37 
MRDR vs lycopene -0.16 0.22 
MRDR vs a-tocopherol -0.16 0.23 
MRDR vs age -0.15 0.34 
3-
•D 
O 
d 
DR/R 
FIG 3. The relationship between the ratio of 3,4-didehydroretinol to retinol (DR/R) and 
serum retinol concentrations in all ethnic groups of pregnant women studied. Non-Hispanic 
White (•), Hispanic (0), Afi-o-American (0) and Asian (A). The formula for the linear 
regression line is y = -15.993x + 1.986, r = -0.48, p < 0.0002. 
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DISCUSSION 
Pregnant women are susceptible to vitamin A depletion because of increased demands 
during pregnancy and altered dietary habits. Although clinical vitamin A deficiency among 
presumably healthy persons, including pregnant women, is rarely observed in the United 
States, plasma vitamin A concentrations are reduced in women during gestation (17-21). A 
25% reduction of serum retinol concentrations, due in part to hemodilution, is typical in 
women followed longitudinally during pregnancy (4). The National Health and Nutrition 
Examination Survey (NHANES 1) and the survey of Hispanic Americans living in the 
southwestern United States (14) both confirm this trend in pregnant females in the United 
States. 
Both the RDR and MRDR tests have been successfully employed to assess marginal 
vitamin A status in humans (6-8, 22-26). As vitamin A is depleted in an individual, the 
MRDR value increases. A tentative cutoff point for individuals has been set at 0.03 in the 
United States (6) and at 0.06 in Indonesia (23, 24). Probable reasons for these geographic 
differences in cutoff values have been discussed (23,24). While these cutoff values may seem 
arbitrary, they are based on the following observations: 1) MRDR ratios of healthy children 
and aduhs in the U.S. are <0.03; 2) MRDR ratios of subjects in the U.S. that are >0.03 fall to 
values <0.03 in all instances following a dose of vitamin A; 3) MRDR ratios in healthy 
Indonesian children are usually <0.06; and 4) MRDR ratios in Indonesia that are >0.06 fall to 
values <0.06 following a dose of vitamin A (23). Thus, DR/R ratios <0.03 imply adequate 
total body reserves of vitamin A, ratios in the 0.03-0.06 range currently are considered as a 
zone of probable inadequacy, and ratios ^0.06 clearly indicate inadequate reserves. 
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In our sample of socioeconomically disadvantaged pregnant vromen, 26% and 9% 
were in a marginal status at the 0.03 and 0.06 cutoff ratios, respectively. This observation 
surprised us, inasmuch as the average intake of vitamin A in pregnant women in the United 
States is approximately 1000 ^ig retinol equivalents (27, 28). On the other hand, the median 
intake is only 540 retinol equivalents (28), primarily because the pattern of vitamin A and 
carotenoid intakes is highly skewed. In general, the nutritional status of lower socioeconomic 
groups tends to be poorer than that of wealthier, better-educated persons. Although all the 
women in this study were eligible for WIC, which provides nutritional advice and muUivitamin 
preparations, advice need not be followed nor vitamin preparations regularly taken. If 
supplements had been ingested, the authors believe that all MRDR values would have been 
<0.03. Most subjects stated they took the vitamin, although validation of their claims was not 
possible. Thus, we conclude that at least one quarter, and probably more, of the subjects did 
not take the supplements on a regular basis, if at all. 
Inadequate maternal vitamin A stores, particularly late in pregnancy, may not provide 
sufficient vitamin A needed by the rapidly growing fetus or, thereafter, satisfactory breast milk 
concentrations. Low birthweight, as a consequence of intrauterine growth retardation, and 
premature birth are both correlated with a low vitamin A status of the mother (3,29). 
Hemodilution of pregnancy is responsible for some reduction of serum vitamin A values. 
However, since the amount of DR-RBP released from the liver is also diluted, the DR/R ratio 
is only minimally affected by hemodilution. 
The Hispanic and Afro-American groups seemed to be most at risk, with 50% and 
40% (respectively) of their MRDR values ^0.03. Unfortunately, great difficulty was 
encountered in recruiting pregnant women from these two racial groups. Hence, the sample 
size is quite small, which reduces the probability of finding statistical differences between 
groups. However, MRDR values >0.06 are quite prevalent in these two groups (33% for 
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Hispanic, 20% for Afro-American) with relatively few present in the non-Hispanic White 
group (4%) (Table 3). Thus, vitamin A inadequacy may not only be more prevalent among 
these racial groups, but also may be more severe. In this regard, pregnant Afro-American 
women have less availability to, and are less likely to receive, timely prenatal care than White 
women (30). Indeed, while most subjects in our study took advantage of the WIC program, 
the Afro-American subjects did not, primarily due to lack of both interest and transportation 
to the clinic. 
Mean serum |J-carotene, a-carotene, and lycopene values in our study population are 
approximately 50%, 50%, and 70%, respectively, of other reported values for healthy non­
pregnant adult females (31, 32). The hemodilution of pregnancy may account for some of this 
difference. Because serum carotenoid values are positively correlated with dietary carotenoid 
intake (33), however, a reduced intake of carotenoids in our study population is likely. Foods 
containing high carotenoid levels, such as fresh fruits and vegetables, are often prohibitive in 
cost for low-income households. Food habits must also play an important role. Serum 
carotenoid levels for the Afro-American group, for example, are extremely low (Table 3), 
while those of the non-Hispanic White, Hispanic and Asian groups of similar socioeconomic 
status are just slightly below levels reported for healthy American women (31, 32). These 
differences between ethnic groups probably are due to dietary variations, but one might 
speculate that genetic differences in carotenoid metabolism may also occur, although no 
supporting data are available. 
The reported mean ratio of serum a-tocopherol to cholesterol among healthy U.S. 
adults is 4.08 ± 0.14 mg/g cholesterol (3.66 jamole/mmole) (34). The mean ratio for each 
ethnic group in the study population falls above this level, which indicates satisfactory vitamin 
E nutriture. Circulating tocopherol levels increase during pregnancy, along with increased 
lipid levels (35). 
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Mean serum cholesterol levels were elevated 24% for the study population relative to 
mean values reported for non-pregnant adult women (5.7 mmol/L vs. 4.6 mmol/L) (16). A 
16% increase in cholesterol concentrations during late pregnancy has been reported (36). 
This increase probably is due to an increase in apolipoprotein A-I and HDL cholesterol 
concentrations. Serum cholesterol values return to normal concentrations postpartum (35). 
When pregnancy is considered, therefore, serum cholesterol levels in our study population do 
not differ markedly from those of women in the general population. 
In summary, a significant number of pregnant women in our study population showed 
an inadequate vitamin A status by application of the sensitive MRDR test. In the only other 
comparable study, conducted among pregnant Indonesian women, the percentages with DR/R 
ratios >0.03 and >0.06 were 52% and 17%, respectively (S. Tanumihardjo and J.A. Olson, 
unpublished observations), just twofold greater than those found here. Thus, vitamin A 
inadequacy among a high-risk group clearly is present in the American population. A 
preliminary report of a portion of this study has been published (37). 
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5. GENERAL SUMMARY 
Adequate vitamin A nutriture is essential for reproduction, immune function, vision, 
and maintenance of cellular differentiation in mammals. During gestation, the supply of 
vitamin A must be strictly regulated, ensuring that adequate, but not teratogenic, levels are 
supplied to the developing offspring. As gestation progresses, increased levels of vitamin A 
are needed to meet the demands of increased cell proliferation, and to muntain maternal 
supplies for adequate breast-milk concentrations. 
The use of 3,4-didehydroretinyl acetate in the MRDR assay has proven to be useful in 
assessing marginal vitamin A status. Twenty six percent of the pregnant women in the lower 
socioeconomic population studied were found to be in less than adequate vitamin A status, 
with MRDR values >0.03, while 9% had values >0.06. Among the ethnic groups tested, 
Hispanic and Afro-American groups were most at risk for vitamin A deficiency, with 50% and 
40% (respectively) of their MRDR values >0.03. MRDR values >0.06 were also quite 
prevalent for these two ethnic groups (33% for Hispanic, 20% for Afi"o-American). Very few 
subjects (4%) in the non-Hispanic White group exhibited MRDR values >0.06. Serum 
carotenoid concentrations for the entire study population were also below average values for 
healthy adult females. Values for the Afro-American group were extremely low, while levels 
for the other ethnic groups were only moderately low. The significant number of subjects in 
our study with inadequate vitamin A status indicates that a portion of socioeconomically 
disadvantaged pregnant women in America are at high-risk for vitamin A delBciency, especially 
among Hispanic and Afro-American groups. 
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The use of vitamin A2 in the MRDR assay has been quite useful. Significant toxicity 
and teratogenicity of A2 seemed unlikely, given that A2 has been shown to be only 30-40% as 
biologically active as A1 in promoting growth. Also, high teratogenic activity of naturally 
occurring retinoids has correlated with the presence of an unsubstituted carboxylic acid group 
at the end of the tetraene chain, which is not present on A2. Thus, the finding that A2 as 
more toxic and teratogenic than A1 by several orders of magnitude was somewhat of a 
surprise. While A2 did not possess the teratogenic potency of RA in our studies, the no 
observable effect level (NOEL) determined for these two compounds in regards to 
embryolethality was the same (3.5 |xmol/kg BW). The biological response to, and 
metabolism of, an increased dose of A2 was also unique compared to other retinoids. An A2 
dose tended to increase concentrations of RA in embryonic and maternal liver tissues, 
correlating with increased teratogenic effects. 
The dose response curve for A2 was also peculiar among retinoids. Teratogenic 
response to retinoids has generally occurred in a dose-dependent manner. However, the 
embiyotoxic potency of A2 tended to peak at a mid-range dose. Likewise, a mid-range A2 
dose produced profound behavioral changes in six week old rats dosed prenatally, while both 
higher and lower doses did not produce changes. Thus, it appears that A2 is metabolized and 
transported in a manner unique among naturally occurring retinoids. Whether this difference 
is mediated by differences in catabolism, differences in binding to nuclear retinoids receptors, 
or both is unclear. 
90 
Extrapolation of these data to determine human risk from a single dose of A2 can be 
made based on the NOEL for A2 in regards to embiyolethality, which was determined to be 
3.5 nmol/kg BW. This amount is 25 fold greater than the amount given to a pregnant woman 
in the third trimester of pregnancy, which is 0.14 ^imol/kg BW. Behavioral effects were seen 
in the female offspring of pregnant rats dosed with A2 at 1 |xmol/kg BW. This is a seven fold 
greater amount than that used in the MRDR for pregnant women. While amounts of A2 given 
to pregnant women are lower than those inducing effects in laboratory animals, a wider 
margin of safety is preferred. Generally, a 100 fold margin of safety is required for 
compounds to be approved for human use by the FDA. While no toxic effects have been 
reported from use of A2 in human populations, our animal studies indicate that using the 
MRDR to assess vitamin A status in pregnant women may be putting the offspring at risk. 
Further investigation into the pharmacokinetics of A2 between the dam and fetal 
compartments is needed to clarify this issue. Studies are also needed to investigate the risk of 
using the MRDR assay in lactating women and small children, since A2 crosses readily into 
breast milk, and the CNS is not fully developed in young humans until approximately six 
months of age. 
Thus vitamin A2 has proven to be quite useful in assessing vitamin A status in a 
population of pregnant women. However, risks may be associated with its use in pregnant 
women, as indicated by the outcome of our animal studies. 
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6. GENERAL CONCLUSIONS 
• A2 is more toxic and teratogenic than A1. 
• Resorption and terata are not necessarily related even with a similar class of compounds 
such as RA, A1 and A2. 
• The biological activity of a compound in growth is not necessarily related to its toxicity. 
• The A2 curve for resorption is not dose dependent. 
• A2 produces significant behavioral changes in rats when given prenatally in a manner that 
is not dose-dependent. 
• Socioeconomically disadvantaged pregnant women in Iowa, particularly fi'om Hispanic 
and Afi-o-American ethnic groups, tend to be at risk of vitamin A deficiency. 
